# AUTO-GENERATED FILE - DO NOT EDIT
# Generated from dih_models/parameters.py
# Run: python tools/generate-variables-yml.py
#
# Use in QMD files with: {{< var param_name >}}
# Citations available as: {{< var param_name_cite >}}
#
# Metadata variables:
#   {{< var total_parameter_count >}} - Number of parameters
#   {{< var total_latex_equation_count >}} - Number of LaTeX equations
#   {{< var total_citation_count >}} - Number of citations
#

"action_time_invest_minutes": "<a href=\"/knowledge/solution/wishocracy#action-steps\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Time to invest\
  \ (minutes) | ✓ High confidence | Unit: minutes | Click to view calculation\">10</a>"
"action_time_recruit_minutes": "<a href=\"/knowledge/solution/wishocracy#action-steps\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Time to recruit\
  \ others (minutes) | ✓ High confidence | Unit: minutes | Click to view calculation\"\
  >15</a>"
"action_time_total_hours": "<a href=\"/knowledge/solution/wishocracy#action-steps\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Total action\
  \ time in hours | ✓ High confidence | Formula: MINUTES ÷ 60 | Unit: hours | Click\
  \ to view calculation\">0.45</a>"
"action_time_total_hours_latex": "$$\nHours = 27 / 60 = 0.45 \\text{ hours}\n$$"
"action_time_total_minutes": "<a href=\"/knowledge/solution/wishocracy#action-steps\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Total time for\
  \ all three actions | ✓ High confidence | Formula: VOTE + INVEST + RECRUIT | Unit:\
  \ minutes | Click to view calculation\">27</a>"
"action_time_total_minutes_latex": "$$\nTotalTime = 2 + 10 + 15 = 27 \\text{ minutes}\n\
  $$"
"action_time_vote_minutes": "<a href=\"/knowledge/solution/wishocracy#action-steps\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Time to vote\
  \ (minutes) | ✓ High confidence | Unit: minutes | Click to view calculation\">2</a>"
"antidepressant_trial_exclusion_rate": "<a href=\"https://warondisease.org/knowledge/references.html#antidepressant-trial-exclusion-rates\"\
  \ class=\"parameter-link\" data-source-ref=\"antidepressant-trial-exclusion-rates\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Mean exclusion\
  \ rate in antidepressant trials (86.1% of real-world patients excluded) | ✓ High\
  \ confidence | Unit: percentage | Click to view source\">86.1%</a>"
"antidepressant_trial_exclusion_rate_cite": "@antidepressant-trial-exclusion-rates"
"average_market_return_pct": "<a href=\"https://warondisease.org/knowledge/references.html#warren-buffett-career-average-return-20-pct\"\
  \ class=\"parameter-link\" data-source-ref=\"warren-buffett-career-average-return-20-pct\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Average annual\
  \ stock market return (10%) | ✓ High confidence | Unit: rate | Click to view source\"\
  >10%</a>"
"average_market_return_pct_cite": "@warren-buffett-career-average-return-20-pct"
"average_us_hourly_wage": "<a href=\"https://warondisease.org/knowledge/references.html#average-us-hourly-wage\"\
  \ class=\"parameter-link\" data-source-ref=\"average-us-hourly-wage\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Average US hourly wage | ✓ High confidence\
  \ | Unit: USD/hour | Click to view source\">$30</a>"
"average_us_hourly_wage_cite": "@average-us-hourly-wage"
"baseline_lives_saved_annual": "<a href=\"https://warondisease.org/knowledge/references.html#who-global-health-estimates-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"who-global-health-estimates-2024\"\
  \ data-source-type=\"external\" data-peer-reviewed=\"true\" data-confidence=\"medium\"\
  \ title=\"Baseline annual lives saved by pharmaceuticals (conservative aggregate)\
  \ | ~ Medium confidence | \U0001F4CA Peer-reviewed | Conservative estimate | Updated:\
  \ 2024 | Unit: deaths/year | Click to view source\">12</a>"
"baseline_lives_saved_annual_cite": "@who-global-health-estimates-2024"
"bed_nets_cost_per_daly": "<a href=\"https://warondisease.org/knowledge/references.html#givewell-cost-per-life-saved\"\
  \ class=\"parameter-link\" data-source-ref=\"givewell-cost-per-life-saved\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"GiveWell cost per DALY for bed nets\
  \ (midpoint estimate, range $78-100) | ✓ High confidence | Unit: USD/DALY | Click\
  \ to view source\">$89</a>"
"bed_nets_cost_per_daly_cite": "@givewell-cost-per-life-saved"
"book_reading_speed_wpm": "<a href=\"https://warondisease.org/knowledge/references.html#average-reading-speed\"\
  \ class=\"parameter-link\" data-source-ref=\"average-reading-speed\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Average reading speed (conservative\
  \ for non-fiction) | ✓ High confidence | Unit: words/minute | Click to view source\"\
  >200</a>"
"book_reading_speed_wpm_cite": "@average-reading-speed"
"book_reading_time_hours": "<a href=\"/knowledge/solution/wishocracy#time-investment\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#time-investment\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Time to read\
  \ the entire book | ✓ High confidence | Formula: (WORDS ÷ SPEED) ÷ 60 | Unit: hours\
  \ | Click to view calculation\">14.3</a>"
"book_reading_time_hours_latex": "$$\nReadTime = \\frac{171,121 / 200}{60} \\approx\
  \ 14.3 \\text{ hours}\n$$"
"campaign_celebrity_endorsement": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Celebrity and\
  \ influencer endorsements | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$15M</a>"
"campaign_community_organizing": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Community organizing\
  \ and ambassador program budget | ✓ High confidence | Unit: USD | Click to view\
  \ calculation\">$30M</a>"
"campaign_contingency": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Contingency fund for unexpected costs\
  \ | ✓ High confidence | 95% CI: [$30M, $80M] | Dist: Uniform | Unit: USD | Click\
  \ to view calculation\">$50M</a>"
"campaign_defense_conversion": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Defense industry conversion program\
  \ | ✓ High confidence | 95% CI: [$40M, $70M] | Dist: Lognormal | Unit: USD | Click\
  \ to view calculation\">$50M</a>"
"campaign_defense_lobbyist_budget": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Budget for co-opting\
  \ defense industry lobbyists | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$50M</a>"
"campaign_healthcare_alignment": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Healthcare industry\
  \ alignment and partnerships | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$35M</a>"
"campaign_infrastructure": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Campaign operational infrastructure\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$20M</a>"
"campaign_legal_ai_budget": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"AI-assisted legal work budget | ✓\
  \ High confidence | Unit: USD | Click to view calculation\">$50M</a>"
"campaign_legal_defense": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Legal defense fund | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$20M</a>"
"campaign_legal_work": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Legal drafting and compliance work\
  \ | ✓ High confidence | 95% CI: [$50M, $80M] | Dist: Lognormal | Unit: USD | Click\
  \ to view calculation\">$60M</a>"
"campaign_lobbying_eu": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"EU lobbying campaign budget | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$40M</a>"
"campaign_lobbying_g20_millions": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"G20 countries\
  \ lobbying budget | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$35M</a>"
"campaign_lobbying_us": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"US lobbying campaign budget | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$50M</a>"
"campaign_media_budget_max": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Maximum mass media campaign budget\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$1.00B</a>"
"campaign_media_budget_min": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Minimum mass media campaign budget\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$500M</a>"
"campaign_opposition_research": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Opposition research\
  \ and rapid response | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$25M</a>"
"campaign_phase1_budget": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Phase 1 campaign budget (Foundation,\
  \ Year 1) | ✓ High confidence | Unit: USD | Click to view calculation\">$200M</a>"
"campaign_phase2_budget": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Phase 2 campaign budget (Scale & Momentum,\
  \ Years 2-3) | ✓ High confidence | Unit: USD | Click to view calculation\">$500M</a>"
"campaign_pilot_programs": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Pilot program testing in small countries\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$30M</a>"
"campaign_platform_development": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Voting platform\
  \ and technology development | ✓ High confidence | 95% CI: [$25M, $50M] | Dist:\
  \ Lognormal | Unit: USD | Click to view calculation\">$35M</a>"
"campaign_regulatory_navigation": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Regulatory compliance\
  \ and navigation | ✓ High confidence | Unit: USD | Click to view calculation\">$20M</a>"
"campaign_scaling_prep": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Scaling preparation and blueprints\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$30M</a>"
"campaign_staff_budget": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Campaign core team staff budget |\
  \ ✓ High confidence | Unit: USD | Click to view calculation\">$40M</a>"
"campaign_super_pac_budget": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Super PAC campaign expenditures |\
  \ ✓ High confidence | Unit: USD | Click to view calculation\">$30M</a>"
"campaign_tech_partnerships": "<a href=\"/knowledge/economics/campaign-budget\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Tech industry partnerships and infrastructure\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$25M</a>"
"campaign_treaty_implementation": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Post-victory\
  \ treaty implementation support | ✓ High confidence | 95% CI: [$30M, $55M] | Dist:\
  \ Lognormal | Unit: USD | Click to view calculation\">$40M</a>"
"campaign_viral_content_budget": "<a href=\"/knowledge/economics/campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Viral marketing\
  \ content creation budget | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$40M</a>"
"caregiver_annual_value_total": "<a href=\"https://warondisease.org/knowledge/references.html#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" data-source-ref=\"unpaid-caregiver-hours-economic-value\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Total annual value\
  \ of unpaid caregiving in US | ✓ High confidence | Unit: USD/year | Click to view\
  \ source\">$600B</a>"
"caregiver_annual_value_total_cite": "@unpaid-caregiver-hours-economic-value"
"caregiver_cost_annual": "<span class=\"parameter-definition\" title=\"Annual cost\
  \ of unpaid caregiving (replacement cost method) | Unit: USD/year | Core definition\"\
  >$6.00K</span>"
"caregiver_count_us": "<a href=\"https://warondisease.org/knowledge/references.html#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" data-source-ref=\"unpaid-caregiver-hours-economic-value\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Number of unpaid\
  \ caregivers in US | ✓ High confidence | Unit: people | Click to view source\">38M</a>"
"caregiver_count_us_cite": "@unpaid-caregiver-hours-economic-value"
"caregiver_hours_per_month": "<a href=\"https://warondisease.org/knowledge/references.html#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" data-source-ref=\"unpaid-caregiver-hours-economic-value\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Average monthly\
  \ hours of unpaid family caregiving in US | ✓ High confidence | Unit: hours/month\
  \ | Click to view source\">20</a>"
"caregiver_hours_per_month_cite": "@unpaid-caregiver-hours-economic-value"
"caregiver_value_per_hour_simple": "<a href=\"https://warondisease.org/knowledge/references.html#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" data-source-ref=\"unpaid-caregiver-hours-economic-value\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Estimated replacement\
  \ cost per hour of caregiving | ✓ High confidence | Unit: USD/hour | Click to view\
  \ source\">$25</a>"
"caregiver_value_per_hour_simple_cite": "@unpaid-caregiver-hours-economic-value"
"childhood_vaccination_annual_benefit": "<a href=\"https://warondisease.org/knowledge/references.html#childhood-vaccination-economic-benefits\"\
  \ class=\"parameter-link\" data-source-ref=\"childhood-vaccination-economic-benefits\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Estimated annual\
  \ global economic benefit from childhood vaccination programs (measles, polio, etc.)\
  \ | ✓ High confidence | Unit: USD/year | Click to view source\">$15B</a>"
"childhood_vaccination_annual_benefit_cite": "@childhood-vaccination-economic-benefits"
"childhood_vaccination_cost_per_daly": "<span class=\"parameter-definition\" title=\"\
  Estimated cost per DALY for US childhood vaccination programs. Note: US cost-effectiveness\
  \ studies primarily use cost per QALY (Quality-Adjusted Life Year) rather than cost\
  \ per DALY. This estimate is derived from program costs and benefits for comparison\
  \ purposes only. | Unit: USD/DALY | Core definition\">$30</span>"
"childhood_vaccination_roi": "<a href=\"https://warondisease.org/knowledge/references.html#childhood-vaccination-roi\"\
  \ class=\"parameter-link\" data-source-ref=\"childhood-vaccination-roi\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Return on investment from childhood\
  \ vaccination programs | ✓ High confidence | Unit: ratio | Click to view source\"\
  >13</a>"
"childhood_vaccination_roi_cite": "@childhood-vaccination-roi"
"chronic_disease_disability_weight": "<a href=\"https://warondisease.org/knowledge/references.html#who-global-health-estimates-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"who-global-health-estimates-2024\"\
  \ data-source-type=\"external\" data-peer-reviewed=\"true\" data-confidence=\"medium\"\
  \ title=\"Disability weight for untreated chronic conditions (WHO Global Burden\
  \ of Disease) | ~ Medium confidence | \U0001F4CA Peer-reviewed | Dist: Normal (SE:\
  \ 0.07) | Unit: weight | Click to view source\">0.35</a>"
"chronic_disease_disability_weight_cite": "@who-global-health-estimates-2024"
"combined_peace_health_dividends_annual_for_roi_calc": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness#combined-dividends\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#combined-dividends\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Combined peace\
  \ and health dividends for ROI calculation | ✓ High confidence | Formula: PEACE_DIVIDEND\
  \ + R&D_SAVINGS | Unit: USD/year | Click to view calculation\">$155B</a>"
"combined_peace_health_dividends_annual_for_roi_calc_latex": "$$\nCombined = \\$113.55B\
  \ + \\$50B = \\$163.55B\n$$"
"current_active_trials": "<a href=\"https://warondisease.org/knowledge/references.html#clinicaltrials-gov-enrollment-data-2025\"\
  \ class=\"parameter-link\" data-source-ref=\"clinicaltrials-gov-enrollment-data-2025\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Current active\
  \ trials at any given time (3-5 year duration) | ✓ High confidence | Unit: trials\
  \ | Click to view source\">10,000</a>"
"current_active_trials_cite": "@clinicaltrials-gov-enrollment-data-2025"
"current_clinical_trial_participation_rate": "<a href=\"https://warondisease.org/knowledge/references.html#clinical-trial-patient-participation-rate\"\
  \ class=\"parameter-link\" data-source-ref=\"clinical-trial-patient-participation-rate\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Current clinical\
  \ trial participation rate (0.06% of population) | ✓ High confidence | Unit: rate\
  \ | Click to view source\">0.06%</a>"
"current_clinical_trial_participation_rate_cite": "@clinical-trial-patient-participation-rate"
"current_disease_patients_global": "<a href=\"https://warondisease.org/knowledge/references.html#disease-prevalence-2-billion\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-prevalence-2-billion\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Global population with chronic diseases\
  \ | ✓ High confidence | Unit: people | Click to view source\">2.40B</a>"
"current_disease_patients_global_cite": "@disease-prevalence-2-billion"
"current_drug_approvals_per_year": "<a href=\"https://warondisease.org/knowledge/references.html#global-new-drug-approvals-50-annually\"\
  \ class=\"parameter-link\" data-source-ref=\"global-new-drug-approvals-50-annually\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Average annual\
  \ new drug approvals globally | ✓ High confidence | Unit: drugs/year | Click to\
  \ view source\">50</a>"
"current_drug_approvals_per_year_cite": "@global-new-drug-approvals-50-annually"
"current_patient_participation_rate": "<span class=\"parameter-definition\" title=\"\
  Current patient participation rate in clinical trials (0.08% = 1.9M participants\
  \ / 2.4B disease patients) | Unit: rate | Core definition\">0.0792%</span>"
"current_patient_participation_rate_latex": "$$\nRate = 1.9M \\div 2.4B = 0.08\\%\n\
  $$"
"current_trials_per_year": "<a href=\"https://warondisease.org/knowledge/references.html#global-clinical-trials-market-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"global-clinical-trials-market-2024\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Current global\
  \ clinical trials per year | ✓ High confidence | Unit: trials/year | Click to view\
  \ source\">3,300</a>"
"current_trials_per_year_cite": "@global-clinical-trials-market-2024"
"current_trial_abandonment_rate": "<a href=\"https://warondisease.org/knowledge/references.html#clinical-trial-abandonment-rate\"\
  \ class=\"parameter-link\" data-source-ref=\"clinical-trial-abandonment-rate\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Current trial abandonment rate (40%\
  \ never complete) | ✓ High confidence | Unit: rate | Click to view source\">40%</a>"
"current_trial_abandonment_rate_cite": "@clinical-trial-abandonment-rate"
"current_trial_slots_available": "<a href=\"https://warondisease.org/knowledge/references.html#global-trial-participant-capacity\"\
  \ class=\"parameter-link\" data-source-ref=\"global-trial-participant-capacity\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual global clinical\
  \ trial participants (IQVIA 2022: 1.9M post-COVID normalization) | ✓ High confidence\
  \ | 95% CI: [1.50M, 2.30M] | Dist: Lognormal | Unit: patients/year | Click to view\
  \ source\">1.90M</a>"
"current_trial_slots_available_cite": "@global-trial-participant-capacity"
"dct_platform_funding_medium": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#analogous-rom\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#analogous-rom\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Mid-range funding\
  \ for commercial DCT platform | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$500M</a>"
"defense_lobbying_annual": "<a href=\"https://warondisease.org/knowledge/references.html#lobbying-spend-defense\"\
  \ class=\"parameter-link\" data-source-ref=\"lobbying-spend-defense\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Annual defense\
  \ industry lobbying spending | ✓ High confidence | \U0001F4CA Peer-reviewed | Updated:\
  \ 2024 | Unit: USD/year | Click to view source\">$127M</a>"
"defense_lobbying_annual_cite": "@lobbying-spend-defense"
"defense_sector_retention_pct": "<span class=\"parameter-definition\" title=\"Percentage\
  \ of budget defense sector keeps under 1% treaty | Unit: rate | Core definition\"\
  >99%</span>"
"deworming_cost_per_daly": "<a href=\"https://warondisease.org/knowledge/references.html#deworming-cost-per-daly\"\
  \ class=\"parameter-link\" data-source-ref=\"deworming-cost-per-daly\" data-source-type=\"\
  external\" data-confidence=\"low\" title=\"Cost per DALY for deworming programs\
  \ (range $28-82, midpoint estimate). GiveWell notes this 2011 estimate is outdated\
  \ and their current methodology focuses on long-term income effects rather than\
  \ short-term health DALYs. | ? Low confidence | Unit: USD/DALY | Click to view source\"\
  >$55</a>"
"deworming_cost_per_daly_cite": "@deworming-cost-per-daly"
"dfda_annual_opex": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#opex-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ dFDA operational costs (sum of all components: $15M + $10M + $8M + $5M + $2M)\
  \ | ✓ High confidence | Formula: PLATFORM_MAINTENANCE + STAFF + INFRASTRUCTURE +\
  \ REGULATORY + COMMUNITY | Unit: USD/year | Click to view calculation\">$40M</a>"
"dfda_annual_opex_latex": "$$\nOPEX_{total} = \\$15M \\text{ (plat)} + \\$10M \\text{\
  \ (staff)} + \\$8M \\text{ (infra)} + \\$5M \\text{ (reg)} + \\$2M \\text{ (comm)}\
  \ = \\$40M\n$$"
"dfda_benefit_rd_only_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#cost-reduction\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#cost-reduction\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual dFDA benefit\
  \ from R&D savings (trial cost reduction, secondary component) | ✓ High confidence\
  \ | Formula: TRIAL_SPENDING × COST_REDUCTION_PCT | Unit: USD/year | Click to view\
  \ calculation\">$41.5B</a>"
"dfda_benefit_rd_only_annual_latex": "$$\nBenefit_{RD} = \\$83B \\times 0.50 = \\\
  $41.5B\n$$"
"dfda_expected_roi_0_1pct_political_success": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ data-source-ref=\"/calculated\" data-source-type=\"calculated\" data-confidence=\"\
  low\" title=\"Expected ROI for 1% Treaty accounting for 0.1% political success probability\
  \ (extremely pessimistic estimate) | ? Low confidence | Formula: TREATY_ROI_LAG_ELIMINATION\
  \ * POLITICAL_SUCCESS_PROBABILITY_EXTREMELY_PESSIMISTIC | Click to view calculation\"\
  >1,191</a>"
"dfda_expected_roi_0_1pct_political_success_latex": "$$\nE[ROI]_{\\text{0.1\\%}} =\
  \ 1{,}286{,}242 \\times 0.001 = 1{,}286\n$$"
"dfda_expected_roi_10pct_political_success": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ data-source-ref=\"/calculated\" data-source-type=\"calculated\" data-confidence=\"\
  medium\" title=\"Expected ROI for 1% Treaty accounting for 10% political success\
  \ probability (conservative estimate) | ~ Medium confidence | Formula: TREATY_ROI_LAG_ELIMINATION\
  \ * POLITICAL_SUCCESS_PROBABILITY_CONSERVATIVE | Click to view calculation\">119K</a>"
"dfda_expected_roi_10pct_political_success_latex": "$$\nE[ROI]_{\\text{10\\%}} = 1{,}286{,}242\
  \ \\times 0.10 = 128{,}624\n$$"
"dfda_expected_roi_1pct_political_success": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ data-source-ref=\"/calculated\" data-source-type=\"calculated\" data-confidence=\"\
  low\" title=\"Expected ROI for 1% Treaty accounting for 1% political success probability\
  \ (very pessimistic estimate) | ? Low confidence | Formula: TREATY_ROI_LAG_ELIMINATION\
  \ * POLITICAL_SUCCESS_PROBABILITY_VERY_PESSIMISTIC | Click to view calculation\"\
  >11,914</a>"
"dfda_expected_roi_1pct_political_success_latex": "$$\nE[ROI]_{\\text{1\\%}} = 1{,}286{,}242\
  \ \\times 0.01 = 12{,}862\n$$"
"dfda_expected_roi_25pct_political_success": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ data-source-ref=\"/calculated\" data-source-type=\"calculated\" data-confidence=\"\
  medium\" title=\"Expected ROI for 1% Treaty accounting for 25% political success\
  \ probability (moderate estimate) | ~ Medium confidence | Formula: TREATY_ROI_LAG_ELIMINATION\
  \ * POLITICAL_SUCCESS_PROBABILITY_MODERATE | Click to view calculation\">298K</a>"
"dfda_expected_roi_25pct_political_success_latex": "$$\nE[ROI]_{\\text{25\\%}} = 1{,}286{,}242\
  \ \\times 0.25 = 321{,}561\n$$"
"dfda_expected_roi_40pct_political_success": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ data-source-ref=\"/calculated\" data-source-type=\"calculated\" data-confidence=\"\
  medium\" title=\"Expected ROI for 1% Treaty accounting for 40% political success\
  \ probability (moderate-high estimate) | ~ Medium confidence | Formula: TREATY_ROI_LAG_ELIMINATION\
  \ * POLITICAL_SUCCESS_PROBABILITY_MODERATE_HIGH | Click to view calculation\">477K</a>"
"dfda_expected_roi_40pct_political_success_latex": "$$\nE[ROI]_{\\text{40\\%}} = 1{,}286{,}242\
  \ \\times 0.40 = 514{,}497\n$$"
"dfda_expected_roi_50pct_political_success": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ data-source-ref=\"/calculated\" data-source-type=\"calculated\" data-confidence=\"\
  medium\" title=\"Expected ROI for 1% Treaty accounting for 50% political success\
  \ probability (optimistic estimate) | ~ Medium confidence | Formula: TREATY_ROI_LAG_ELIMINATION\
  \ * POLITICAL_SUCCESS_PROBABILITY_OPTIMISTIC | Click to view calculation\">596K</a>"
"dfda_expected_roi_50pct_political_success_latex": "$$\nE[ROI]_{\\text{50\\%}} = 1{,}286{,}242\
  \ \\times 0.50 = 643{,}121\n$$"
"dfda_net_savings_rd_only_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#net-savings\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#net-savings\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual net savings\
  \ from R&D cost reduction only (gross savings minus operational costs, excludes\
  \ regulatory delay value) | ✓ High confidence | Formula: GROSS_SAVINGS - ANNUAL_OPEX\
  \ | Unit: USD/year | Click to view calculation\">$41.5B</a>"
"dfda_net_savings_rd_only_annual_latex": "$$\nSavings_{net} = \\$41.5B - \\$0.04B\
  \ = \\$41.46B\n$$"
"dfda_npv_adoption_ramp_years": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#adoption-curve\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#adoption-curve\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Years to reach\
  \ full dFDA adoption | ✓ High confidence | Unit: years | Click to view calculation\"\
  >5</a>"
"dfda_npv_annual_opex": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA core platform\
  \ annual opex (midpoint of $11-26.5M) | ✓ High confidence | 95% CI: [$11M, $26.5M]\
  \ | Dist: Lognormal | Unit: USD/year | Click to view calculation\">$18.9M</a>"
"dfda_npv_annual_opex_total": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total NPV annual\
  \ opex (dFDA core + DIH initiatives) | ✓ High confidence | Formula: DFDA_OPEX +\
  \ DIH_OPEX | Unit: USD/year | Click to view calculation\">$40M</a>"
"dfda_npv_annual_opex_total_latex": "$$\nC_{op} = \\$0.01895B + \\$0.02110B = \\$0.04005B\
  \ \\text{ (annual operational cost)}\n$$"
"dfda_npv_benefit_rd_only": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-benefit\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-benefit\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"NPV of dFDA R&D\
  \ savings only with 5-year adoption ramp (10-year horizon, most conservative financial\
  \ estimate) | ✓ High confidence | Formula: Sum of discounted annual net R&D savings\
  \ with linear adoption ramp | Unit: USD | Click to view calculation\">$207B</a>"
"dfda_npv_benefit_rd_only_latex": "$$\nPV_{benefits} = \\sum_{t=1}^{10} \\frac{NetSavings_{RD}\
  \ \\times \\min(t,5)/5}{(1+r)^t} \\approx \\$249.3B \\text{ (5-year linear adoption\
  \ ramp)}\n$$"
"dfda_npv_net_benefit_rd_only": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-net-benefit\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-net-benefit\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"NPV net benefit\
  \ using R&D savings only (most conservative financial estimate, excludes regulatory\
  \ delay health value) | ✓ High confidence | Formula: NPV of net R&D savings with\
  \ 5-year linear adoption ramp | Unit: USD | Click to view calculation\">$207B</a>"
"dfda_npv_net_benefit_rd_only_latex": "$$\nBenefit_{NPV} = \\sum_{t=1}^{10} \\frac{NetSavings_{RD}\
  \ \\times \\min(t,5)/5}{(1+r)^t} \\approx \\$249.3B \\text{ (5-year linear adoption\
  \ ramp)}\n$$"
"dfda_npv_pv_annual_opex": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-calculation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-calculation\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Present value\
  \ of annual opex over 10 years (NPV formula) | ✓ High confidence | Formula: OPEX\
  \ × [(1 - (1 + r)^-T) / r] | Unit: USD | Click to view calculation\">$269M</a>"
"dfda_npv_pv_annual_opex_latex": "$$\nPV_{opex} = \\$0.04005B \\times \\frac{1 - 1.08^{-10}}{0.08}\
  \ \\approx \\$0.269B\n$$"
"dfda_npv_total_cost": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-total-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-total-cost\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total NPV cost\
  \ (upfront + PV of annual opex) | ✓ High confidence | Formula: UPFRONT + PV_OPEX\
  \ | Unit: USD | Click to view calculation\">$538M</a>"
"dfda_npv_total_cost_latex": "$$\nTotalCost_{NPV} = \\$0.26975B + \\$0.269B \\approx\
  \ \\$0.54B\n$$"
"dfda_npv_upfront_cost": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA core platform\
  \ build cost | ✓ High confidence | 95% CI: [$25M, $65M] | Dist: Lognormal | Unit:\
  \ USD | Click to view calculation\">$40M</a>"
"dfda_npv_upfront_cost_total": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total NPV upfront\
  \ costs (dFDA core + DIH initiatives) | ✓ High confidence | Formula: DFDA_BUILD\
  \ + DIH_INITIATIVES | Unit: USD | Click to view calculation\">$270M</a>"
"dfda_npv_upfront_cost_total_latex": "$$\nC_0 = \\$0.040B + \\$0.22975B = \\$0.26975B\
  \ \\text{ (upfront cost)}\n$$"
"dfda_opex_community": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#opex-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA community\
  \ support costs | ✓ High confidence | 95% CI: [$1.00M, $3.00M] | Dist: Lognormal\
  \ | Unit: USD/year | Click to view calculation\">$2.00M</a>"
"dfda_opex_infrastructure": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#opex-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA infrastructure\
  \ costs (cloud, security) | ✓ High confidence | 95% CI: [$5.00M, $12M] | Dist: Lognormal\
  \ | Unit: USD/year | Click to view calculation\">$8.00M</a>"
"dfda_opex_pct_of_treaty_funding": "<a href=\"/knowledge/economics/economics#funding-allocation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd#funding-allocation\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Percentage of\
  \ treaty funding allocated to dFDA platform overhead | ✓ High confidence | Formula:\
  \ DFDA_OPEX / TREATY_FUNDING | Unit: rate | Click to view calculation\">0.147%</a>"
"dfda_opex_pct_of_treaty_funding_latex": "$$\nDFDAOpexPct = \\$0.04B / \\$27.18B =\
  \ 0.00147 = 0.15\\%\n$$"
"dfda_opex_platform_maintenance": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#opex-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA platform\
  \ maintenance costs | ✓ High confidence | 95% CI: [$10M, $22M] | Dist: Lognormal\
  \ | Unit: USD/year | Click to view calculation\">$15M</a>"
"dfda_opex_regulatory": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#opex-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA regulatory\
  \ coordination costs | ✓ High confidence | 95% CI: [$3.00M, $8.00M] | Dist: Lognormal\
  \ | Unit: USD/year | Click to view calculation\">$5.00M</a>"
"dfda_opex_staff": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#opex-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA staff costs\
  \ (minimal, AI-assisted) | ✓ High confidence | 95% CI: [$7.00M, $15M] | Dist: Lognormal\
  \ | Unit: USD/year | Click to view calculation\">$10M</a>"
"dfda_rd_gross_savings_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#cost-reduction\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#cost-reduction\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual dFDA benefit\
  \ from R&D savings (trial cost reduction, secondary component) | ✓ High confidence\
  \ | Formula: TRIAL_SPENDING × COST_REDUCTION_PCT | Unit: USD/year | Click to view\
  \ calculation\">$41.5B</a>"
"dfda_rd_gross_savings_annual_latex": "$$\nBenefit_{RD} = \\$83B \\times 0.50 = \\\
  $41.5B\n$$"
"dfda_rd_savings_daily": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#daily-opportunity-cost-of-inaction\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#daily-opportunity-cost-of-inaction\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Daily R&D savings\
  \ from trial cost reduction (opportunity cost of delay) | ✓ High confidence | Formula:\
  \ ANNUAL_RD_SAVINGS ÷ 365 | Unit: USD/day | Click to view calculation\">$114M</a>"
"dfda_rd_savings_daily_latex": "$$\nSavings_{daily} = \\$41.5B \\div 365 = \\$113.7M\n\
  $$"
"dfda_roi_rd_only": "<a href=\"/knowledge/figures/dfda-roi-analysis\" class=\"parameter-link\"\
  \ data-source-ref=\"/knowledge/figures/dfda-roi-analysis.qmd\" data-source-type=\"\
  calculated\" data-confidence=\"high\" title=\"ROI from dFDA R&D savings only (10-year\
  \ NPV, most conservative estimate) | ✓ High confidence | Formula: NPV_BENEFIT ÷\
  \ NPV_TOTAL_COST | Unit: ratio | Click to view calculation\">384</a>"
"dfda_roi_rd_only_latex": "$$\nROI_{RD} = \\frac{\\$249.3B}{\\$0.54B} \\approx 463\n\
  $$"
"dfda_roi_simple": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#roi-simple\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#roi-simple\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Simple ROI without\
  \ NPV adjustment (gross savings / annual opex) | ✓ High confidence | Formula: GROSS_SAVINGS\
  \ ÷ ANNUAL_OPEX | Unit: ratio | Click to view calculation\">1,038</a>"
"dfda_roi_simple_latex": "$$\nROI_{simple} = \\frac{\\$41.5B}{\\$0.04B} = 1,038:1\n\
  $$"
"dfda_target_cost_per_patient_usd": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#cost-per-patient\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#cost-per-patient\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Target cost per\
  \ patient in USD (same as DFDA_TARGET_COST_PER_PATIENT but in dollars) | ✓ High\
  \ confidence | Unit: USD/patient | Click to view calculation\">$1.00K</a>"
"dfda_trials_per_year_capacity": "<span class=\"parameter-link\" title=\"parameters.DFDA_TRIALS_PER_YEAR_CAPACITY\"\
  >84,834</span>"
"dfda_trials_per_year_capacity_latex": "$$\nTrials_{dFDA} = 3,300 \\times 25.7 = 84,800\n\
  $$"
"dfda_upfront_build": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#build-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#build-costs\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA platform\
  \ one-time build cost (central estimate) | ✓ High confidence | Unit: USD | Click\
  \ to view calculation\">$40M</a>"
"dfda_upfront_build_max": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#build-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#build-costs\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"dFDA platform\
  \ one-time build cost (high estimate) | ✓ High confidence | Unit: USD | Click to\
  \ view calculation\">$46M</a>"
"dih_npv_annual_opex_initiatives": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"DIH broader initiatives\
  \ annual opex (medium case) | ✓ High confidence | 95% CI: [$14M, $32M] | Dist: Lognormal\
  \ | Unit: USD/year | Click to view calculation\">$21.1M</a>"
"dih_npv_upfront_cost_initiatives": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis#npv-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"DIH broader initiatives\
  \ upfront cost (medium case) | ✓ High confidence | 95% CI: [$150M, $350M] | Dist:\
  \ Lognormal | Unit: USD | Click to view calculation\">$230M</a>"
"dih_patients_fundable_annually": "<a href=\"/knowledge/economics/economics#funding-allocation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd#funding-allocation\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Number of patients\
  \ fundable annually at RECOVERY trial cost | ✓ High confidence | Formula: TRIAL_SUBSIDIES\
  \ ÷ COST_PER_PATIENT | Unit: patients/year | Click to view calculation\">48.8M</a>"
"dih_patients_fundable_annually_latex": "$$\nPatientsFundable = \\$24.422B \\div \\\
  $500 = 48.8M\n$$"
"dih_treasury_medical_research_pct": "<a href=\"/knowledge/economics/economics#funding-allocation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd#funding-allocation\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Percentage of\
  \ treaty funding allocated to medical research (after bond payouts) | ✓ High confidence\
  \ | Formula: MEDICAL_RESEARCH_FUNDING / TREATY_FUNDING | Unit: rate | Click to view\
  \ calculation\">90%</a>"
"dih_treasury_medical_research_pct_latex": "$$\nMedicalResearchPct = \\$24.462B /\
  \ \\$27.18B = 0.90 = 90\\%\n$$"
"dih_treasury_to_medical_research_annual": "<span class=\"parameter-definition\" title=\"\
  Annual funding for medical research (treaty funding minus bond payouts) | Unit:\
  \ USD/year | Core definition\">$24.5B</span>"
"dih_treasury_to_medical_research_annual_latex": "$$\nResearchFunding = \\$27.18B\
  \ - \\$2.718B = \\$24.462B\n$$"
"dih_treasury_trial_subsidies_annual": "<a href=\"/knowledge/economics/economics#funding-allocation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd#funding-allocation\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual clinical\
  \ trial patient subsidies (all medical research funds after dFDA operations) | ✓\
  \ High confidence | Formula: MEDICAL_RESEARCH_FUNDING - DFDA_OPEX | Unit: USD/year\
  \ | Click to view calculation\">$24.4B</a>"
"dih_treasury_trial_subsidies_annual_latex": "$$\nTrialSubsidies = \\$24.462B - \\\
  $0.04B = \\$24.422B\n$$"
"dih_treasury_trial_subsidies_pct": "<a href=\"/knowledge/economics/economics#funding-allocation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd#funding-allocation\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Percentage of\
  \ treaty funding going directly to patient trial subsidies | ✓ High confidence |\
  \ Formula: TRIAL_SUBSIDIES / TREATY_FUNDING | Unit: rate | Click to view calculation\"\
  >89.9%</a>"
"dih_treasury_trial_subsidies_pct_latex": "$$\nTrialSubsidiesPct = \\$24.422B / \\\
  $27.18B = 0.8986 = 89.86\\%\n$$"
"disease_eradication_delay_dalys": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#daly-calculation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#daly-calculation\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Total Disability-Adjusted\
  \ Life Years lost from disease eradication delay (PRIMARY estimate) | ~ Medium confidence\
  \ | Formula: YLL + YLD | Unit: DALYs | Click to view calculation\">7.94B</a>"
"disease_eradication_delay_dalys_latex": "$$\nDALY_{total} = 7.03B \\text{ (YLL)}\
  \ + 0.87B \\text{ (YLD)} = 7.90B\n$$"
"disease_eradication_delay_deaths_total": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#disease-eradication-delay\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#disease-eradication-delay\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Total eventually\
  \ avoidable deaths from delaying disease eradication by 8.2 years (PRIMARY estimate,\
  \ conservative). Excludes fundamentally unavoidable deaths (primarily accidents\
  \ ~7.9%). | ~ Medium confidence | Formula: ANNUAL_DEATHS × EFFICACY_LAG_YEARS ×\
  \ EVENTUALLY_AVOIDABLE_DEATH_PCT | Unit: deaths | Click to view calculation\">416M</a>"
"disease_eradication_delay_deaths_total_latex": "$$\nD_{total} = 54.75M \\text{ (annual)}\
  \ \\times 8.2 \\text{ (lag)} \\times 92.1\\% \\text{ (avoidable)} = 413.4M\n$$"
"disease_eradication_delay_economic_loss": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#economic-valuation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#economic-valuation\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Total economic\
  \ loss from delaying disease eradication by 8.2 years (PRIMARY estimate, 2024 USD).\
  \ Values global DALYs at standardized US/International normative rate ($150k) rather\
  \ than local ability-to-pay, representing the full human capital loss. | ~ Medium\
  \ confidence | Formula: DALYS_TOTAL × VSLY | Unit: USD | Click to view calculation\"\
  >$1.19 quadrillion</a>"
"disease_eradication_delay_economic_loss_latex": "$$\nLoss = 7.90B \\times \\$150k\
  \ = \\$1.185\\text{ quadrillion}\n$$"
"disease_eradication_delay_yld": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#daly-calculation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#daly-calculation\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Years Lived\
  \ with Disability during disease eradication delay (PRIMARY estimate) | ~ Medium\
  \ confidence | Formula: DEATHS_TOTAL × SUFFERING_PERIOD × DISABILITY_WEIGHT | Unit:\
  \ years | Click to view calculation\">873M</a>"
"disease_eradication_delay_yld_latex": "$$\nYLD = 413.4M \\times 6 \\times 0.35 =\
  \ 868M\n$$"
"disease_eradication_delay_yll": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#daly-calculation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#daly-calculation\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Years of Life\
  \ Lost from disease eradication delay deaths (PRIMARY estimate) | ~ Medium confidence\
  \ | Formula: DEATHS_TOTAL × (LIFE_EXPECTANCY - MEAN_AGE_OF_DEATH) | Unit: years\
  \ | Click to view calculation\">7.07B</a>"
"disease_eradication_delay_yll_latex": "$$\nYLL = 413.4M \\times 17 \\text{ (years\
  \ lost)} = 7.03B\n$$"
"disease_eradication_plus_acceleration_deaths_total": "<a href=\"/knowledge/references#pharmaceutical-innovation-acceleration-economics\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/references.qmd#pharmaceutical-innovation-acceleration-economics\"\
  \ data-source-type=\"calculated\" data-confidence=\"low\" title=\"Total deaths from\
  \ disease eradication delay plus innovation acceleration (OPTIMISTIC UPPER BOUND).\
  \ Represents additional deaths avoided beyond lag elimination through innovation\
  \ cascade effects: faster development cycles, lower barriers enabling more drugs,\
  \ earlier phase starts. The 2× multiplier is supported by research showing 50% timeline\
  \ reductions achievable (Nature 2023) and adaptive trials generating millions of\
  \ additional life-years (Woods et al. 2024). Based on (150K daily × 365 × 2) × 8.2\
  \ years. | ? Low confidence | Formula: (ANNUAL_DEATHS × 2) × EFFICACY_LAG_YEARS\
  \ | Unit: deaths | Click to view calculation\">898M</a>"
"disease_eradication_plus_acceleration_deaths_total_latex": "$$\nD_{total} = (54.75M\
  \ \\times 2) \\times 8.2 = 898M\n$$"
"disease_eradication_plus_acceleration_economic_loss_total": "<a href=\"/knowledge/references#pharmaceutical-innovation-acceleration-economics\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/references.qmd#pharmaceutical-innovation-acceleration-economics\"\
  \ data-source-type=\"calculated\" data-confidence=\"low\" title=\"Total economic\
  \ loss from disease eradication delay plus innovation acceleration (OPTIMISTIC UPPER\
  \ BOUND). The 2× multiplier represents combined timeline and volume effects from\
  \ eliminating Phase 2-4 cost barriers. Research shows: (1) Timeline acceleration\
  \ of 50% achievable through AI/tech (Nature 2023), (2) Adaptive trials can reduce\
  \ costs $2.6B→$2.2B, generating 3.5M additional life-years (Woods et al. 2024, Health\
  \ Economics), (3) Cost barrier elimination enables more drugs to reach viability.\
  \ The 2× factor conservatively represents either 2× timeline acceleration OR 1.5×\
  \ timeline × 1.33× volume. Dynamic efficiency framework suggests optimal manufacturer\
  \ value share ~20% maximizes long-term population health (Woods 2024). | ? Low confidence\
  \ | Formula: PRIMARY_TOTAL × 2 (combined timeline + volume effects) | Unit: USD\
  \ | Click to view calculation\">$2.38 quadrillion</a>"
"disease_eradication_plus_acceleration_economic_loss_total_latex": "$$\nLoss_{total}\
  \ = \\$1,286T \\times 2 = \\$2,572T\n$$"
"disease_related_caregiver_pct": "<a href=\"/disease-related-caregiving-estimate\"\
  \ class=\"parameter-link\" data-source-ref=\"/disease-related-caregiving-estimate\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Percentage of\
  \ caregiving for treatable disease conditions (vs aging, disability, children) |\
  \ ✓ High confidence | Unit: rate | Click to view calculation\">40%</a>"
"disease_vs_terrorism_deaths_ratio": "<a href=\"/knowledge/economics/economics\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Ratio of annual disease deaths to\
  \ 9/11 terrorism deaths | ✓ High confidence | Formula: ANNUAL_DISEASE_DEATHS ÷ 911_DEATHS\
  \ | Unit: ratio | Click to view calculation\">18,274</a>"
"disease_vs_terrorism_deaths_ratio_latex": "$$\n\\frac{54.75\\text{M disease deaths}}{3{,}000\\\
  text{ terrorism deaths}} \\approx 18{,}274:1\n$$"
"disease_vs_war_deaths_ratio": "<a href=\"/knowledge/economics/economics\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Ratio of annual disease deaths to\
  \ war deaths | ✓ High confidence | Formula: ANNUAL_DISEASE_DEATHS ÷ WAR_DEATHS |\
  \ Unit: ratio | Click to view calculation\">224</a>"
"disease_vs_war_deaths_ratio_latex": "$$\n\\frac{54.75\\text{M disease deaths}}{400{,}000\\\
  text{ conflict deaths}} \\approx 137:1\n$$"
"dividend_coverage_factor": "<a href=\"/knowledge/strategy/roadmap#sustainability\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/strategy/roadmap.qmd#sustainability\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Coverage factor\
  \ of treaty funding vs dFDA opex (sustainability margin) | ✓ High confidence | Formula:\
  \ TREATY_FUNDING ÷ DFDA_OPEX | Unit: ratio | Click to view calculation\">680</a>"
"dividend_coverage_factor_latex": "$$\nCoverage = \\$27.18B / \\$0.04B = 679x\n$$"
"drug_cost_increase_1980s_to_current_multiplier": "<a href=\"/pre-1962-drug-costs-timeline\"\
  \ class=\"parameter-link\" data-source-ref=\"/pre-1962-drug-costs-timeline\" data-source-type=\"\
  calculated\" data-confidence=\"high\" title=\"Drug development cost increase from\
  \ 1980s to current ($194M → $2.6B = 13.4x) | ✓ High confidence | Formula: PHARMA_DRUG_DEVELOPMENT_COST_CURRENT\
  \ ÷ DRUG_DEVELOPMENT_COST_1980S | Unit: ratio | Click to view calculation\">13.4</a>"
"drug_cost_increase_1980s_to_current_multiplier_latex": "$$\n\\frac{\\$2.6B}{\\$194M}\
  \ = 13.4\n$$"
"drug_cost_increase_pre1962_to_current_multiplier": "<a href=\"/pre-1962-drug-costs-timeline\"\
  \ class=\"parameter-link\" data-source-ref=\"/pre-1962-drug-costs-timeline\" data-source-type=\"\
  calculated\" data-confidence=\"medium\" title=\"Drug development cost increase from\
  \ pre-1962 to current ($50M → $2.6B = 52x) | ~ Medium confidence | Formula: PHARMA_DRUG_DEVELOPMENT_COST_CURRENT\
  \ ÷ PRE_1962_DRUG_DEVELOPMENT_COST | Unit: ratio | Click to view calculation\">52</a>"
"drug_cost_increase_pre1962_to_current_multiplier_latex": "$$\n\\frac{\\$2.6B}{\\\
  $50M} = 52\n$$"
"drug_development_cost_1980s": "<a href=\"https://warondisease.org/knowledge/references.html#pre-1962-drug-costs-timeline\"\
  \ class=\"parameter-link\" data-source-ref=\"pre-1962-drug-costs-timeline\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Drug development cost in 1980s (compounded\
  \ to approval, 1990 dollars) | ✓ High confidence | Unit: USD | Click to view source\"\
  >$194M</a>"
"drug_development_cost_1980s_cite": "@pre-1962-drug-costs-timeline"
"economic_multiplier_education_investment": "<a href=\"https://warondisease.org/knowledge/references.html#education-investment-economic-multiplier\"\
  \ class=\"parameter-link\" data-source-ref=\"education-investment-economic-multiplier\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Economic multiplier\
  \ for education investment (2.1x ROI) | ✓ High confidence | Unit: ratio | Click\
  \ to view source\">2.1</a>"
"economic_multiplier_education_investment_cite": "@education-investment-economic-multiplier"
"economic_multiplier_healthcare_investment": "<a href=\"https://warondisease.org/knowledge/references.html#healthcare-investment-economic-multiplier\"\
  \ class=\"parameter-link\" data-source-ref=\"healthcare-investment-economic-multiplier\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Economic multiplier\
  \ for healthcare investment (4.3x ROI) | ✓ High confidence | Unit: ratio | Click\
  \ to view source\">4.3</a>"
"economic_multiplier_healthcare_investment_cite": "@healthcare-investment-economic-multiplier"
"economic_multiplier_infrastructure_investment": "<a href=\"https://warondisease.org/knowledge/references.html#infrastructure-investment-economic-multiplier\"\
  \ class=\"parameter-link\" data-source-ref=\"infrastructure-investment-economic-multiplier\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Economic multiplier\
  \ for infrastructure investment (1.6x ROI) | ✓ High confidence | Unit: ratio | Click\
  \ to view source\">1.6</a>"
"economic_multiplier_infrastructure_investment_cite": "@infrastructure-investment-economic-multiplier"
"economic_multiplier_military_spending": "<a href=\"https://warondisease.org/knowledge/references.html#military-spending-economic-multiplier\"\
  \ class=\"parameter-link\" data-source-ref=\"military-spending-economic-multiplier\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Economic multiplier\
  \ for military spending (0.6x ROI) | ✓ High confidence | Unit: ratio | Click to\
  \ view source\">0.6</a>"
"economic_multiplier_military_spending_cite": "@military-spending-economic-multiplier"
"effective_hourly_rate": "<a href=\"/knowledge/solution/wishocracy#effective-hourly-rate\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#effective-hourly-rate\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Effective hourly\
  \ rate from treaty participation | ✓ High confidence | Formula: LIFETIME_BENEFIT\
  \ ÷ TIME_INVESTED | Unit: USD/hour | Click to view calculation\">$292K</a>"
"effective_hourly_rate_latex": "$$\nHourlyRate = \\frac{\\$4,300,000}{14.75} \\approx\
  \ \\$291,525/hr\n$$"
"effective_hourly_rate_lifetime_benefit": "<a href=\"/knowledge/appendix/disease-eradication-personal-lifetime-wealth-calculations\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/disease-eradication-personal-lifetime-wealth-calculations.qmd\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Lifetime benefit\
  \ for age 30 baseline scenario ($4.3M) | ✓ High confidence | Formula: Total lifetime\
  \ health gains from 1% Treaty | Unit: USD | Click to view calculation\">$4.30M</a>"
"effective_hourly_rate_lifetime_benefit_latex": "$$\nBenefit = \\$4,300,000\n$$"
"efficacy_lag_years": "<a href=\"https://warondisease.org/knowledge/references.html#bio-clinical-development-2021\"\
  \ class=\"parameter-link\" data-source-ref=\"bio-clinical-development-2021\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Regulatory\
  \ delay for efficacy testing (Phase II/III) post-safety verification | ✓ High confidence\
  \ | \U0001F4CA Peer-reviewed | Dist: Normal (SE: 1) | Updated: 2021 | Formula: TOTAL_TIME_TO_MARKET\
  \ - PHASE_1_DURATION | Unit: years | Click to view source\">8.2</a>"
"efficacy_lag_years_cite": "@bio-clinical-development-2021"
"efficacy_lag_years_latex": "$$\nt_{lag} = 10.5 - 2.3 = 8.2 \\text{ years}\n$$"
"eventually_avoidable_death_pct": "<span class=\"parameter-definition\" title=\"Percentage\
  \ of deaths that are eventually avoidable with sufficient biomedical research and\
  \ technological advancement | Unit: percentage | Core definition\">92.6%</span>"
"eventually_avoidable_death_pct_latex": "$$\nP_{\\text{avoidable}} = 1 - 0.0791 =\
  \ 92.09\\%\n$$"
"family_office_investment_min": "<a href=\"/knowledge/economics/victory-bonds\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/victory-bonds.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Minimum investment for family offices\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$5.00M</a>"
"fda_phase_1_to_approval_years": "<a href=\"https://warondisease.org/knowledge/references.html#fda-approval-timeline-10-years\"\
  \ class=\"parameter-link\" data-source-ref=\"fda-approval-timeline-10-years\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"FDA timeline from Phase 1 start to approval\
  \ (Phase 1-3 + NDA review) | ✓ High confidence | 95% CI: [6, 12] | Dist: Gamma (SE:\
  \ 2) | Unit: years | Click to view source\">9.1</a>"
"fda_phase_1_to_approval_years_cite": "@fda-approval-timeline-10-years"
"fda_to_oxford_recovery_trial_time_multiplier": "<a href=\"/recovery-trial-82x-cost-reduction\"\
  \ class=\"parameter-link\" data-source-ref=\"/recovery-trial-82x-cost-reduction\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"FDA approval\
  \ timeline vs Oxford RECOVERY trial (9.1 years ÷ 3 months = 36x slower) | ✓ High\
  \ confidence | Formula: FDA_PHASE_1_TO_APPROVAL_YEARS × 12 ÷ OXFORD_RECOVERY_TRIAL_DURATION_MONTHS\
  \ | Unit: ratio | Click to view calculation\">36.4</a>"
"fda_to_oxford_recovery_trial_time_multiplier_latex": "$$\n\\frac{9.1 \\text{ years}\
  \ \\times 12 \\text{ months/year}}{3 \\text{ months}} = 36.4\n$$"
"fundamentally_unavoidable_death_pct": "<span class=\"parameter-definition\" title=\"\
  Percentage of deaths that are fundamentally unavoidable even with perfect biotechnology\
  \ (primarily accidents). Calculated as Σ(disease_burden × (1 - max_cure_potential))\
  \ across all disease categories. | Unit: percentage | Core definition\">7.37%</span>"
"fundamentally_unavoidable_death_pct_latex": "$$\nP_{\\text{unavoidable}} = \\sum_{\\\
  text{categories}} (\\text{disease burden} \\times (1 - \\text{max cure rate})) =\
  \ 7.91\\%\n$$"
"gdp_growth_boost_10pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_10PCT\"\
  >0.025</span>"
"gdp_growth_boost_1pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_1PCT\
  \ - Just the boost component\">0.0025</span>"
"gdp_growth_boost_2pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_2PCT\"\
  >0.005</span>"
"gdp_growth_boost_5pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_5PCT\"\
  >0.0125</span>"
"givewell_cost_per_life_avg": "<a href=\"https://warondisease.org/knowledge/references.html#givewell-cost-per-life-saved\"\
  \ class=\"parameter-link\" data-source-ref=\"givewell-cost-per-life-saved\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"GiveWell average cost per life saved\
  \ across top charities | ✓ High confidence | Unit: USD/life | Click to view source\"\
  >$4.50K</a>"
"givewell_cost_per_life_avg_cite": "@givewell-cost-per-life-saved"
"givewell_cost_per_life_max": "<a href=\"https://warondisease.org/knowledge/references.html#givewell-cost-per-life-saved\"\
  \ class=\"parameter-link\" data-source-ref=\"givewell-cost-per-life-saved\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"GiveWell cost per life saved (Against\
  \ Malaria Foundation) | ✓ High confidence | Unit: USD/life | Click to view source\"\
  >$5.50K</a>"
"givewell_cost_per_life_max_cite": "@givewell-cost-per-life-saved"
"givewell_cost_per_life_min": "<a href=\"https://warondisease.org/knowledge/references.html#givewell-cost-per-life-saved\"\
  \ class=\"parameter-link\" data-source-ref=\"givewell-cost-per-life-saved\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"GiveWell cost per life saved (Helen\
  \ Keller International) | ✓ High confidence | Unit: USD/life | Click to view source\"\
  >$3.50K</a>"
"givewell_cost_per_life_min_cite": "@givewell-cost-per-life-saved"
"global_annual_conflict_deaths_active_combat": "<a href=\"https://warondisease.org/knowledge/references.html#acled-active-combat-deaths\"\
  \ class=\"parameter-link\" data-source-ref=\"acled-active-combat-deaths\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual deaths from active combat worldwide\
  \ | ✓ High confidence | 95% CI: [180K, 300K] | Dist: Lognormal | Unit: deaths/year\
  \ | Click to view source\">234K</a>"
"global_annual_conflict_deaths_active_combat_cite": "@acled-active-combat-deaths"
"global_annual_conflict_deaths_state_violence": "<a href=\"https://warondisease.org/knowledge/references.html#ucdp-state-violence-deaths\"\
  \ class=\"parameter-link\" data-source-ref=\"ucdp-state-violence-deaths\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual deaths from state violence |\
  \ ✓ High confidence | 95% CI: [1,500, 5,000] | Dist: Lognormal | Unit: deaths/year\
  \ | Click to view source\">2,700</a>"
"global_annual_conflict_deaths_state_violence_cite": "@ucdp-state-violence-deaths"
"global_annual_conflict_deaths_terror_attacks": "<a href=\"https://warondisease.org/knowledge/references.html#gtd-terror-attack-deaths\"\
  \ class=\"parameter-link\" data-source-ref=\"gtd-terror-attack-deaths\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual deaths from terror attacks globally\
  \ | ✓ High confidence | 95% CI: [6,000, 12,000] | Dist: Lognormal | Unit: deaths/year\
  \ | Click to view source\">8,300</a>"
"global_annual_conflict_deaths_terror_attacks_cite": "@gtd-terror-attack-deaths"
"global_annual_conflict_deaths_total": "<a href=\"/knowledge/problem/cost-of-war#death-accounting\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#death-accounting\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ conflict deaths globally (sum of combat, terror, state violence) | ✓ High confidence\
  \ | Formula: COMBAT + TERROR + STATE_VIOLENCE | Unit: deaths/year | Click to view\
  \ calculation\">245K</a>"
"global_annual_conflict_deaths_total_latex": "$$\nDeaths_{total} = 233,600 \\text{\
  \ (combat)} + 8,300 \\text{ (terror)} + 2,700 \\text{ (state)} = 244,600\n$$"
"global_annual_deaths_curable_diseases": "<a href=\"/knowledge/economics/economics\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual deaths\
  \ from curable diseases globally | ✓ High confidence | Formula: GLOBAL_DAILY_DEATHS_CURABLE_DISEASES\
  \ × 365 | Unit: deaths/year | Click to view calculation\">54.8M</a>"
"global_annual_deaths_curable_diseases_latex": "$$\nDeaths_{annual} = 150{,}000 \\\
  times 365 = 54.75M\n$$"
"global_annual_environmental_damage_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#environmental-cost-of-war\"\
  \ class=\"parameter-link\" data-source-ref=\"environmental-cost-of-war\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual environmental damage and restoration\
  \ costs from conflict | ✓ High confidence | 95% CI: [$70B, $140B] | Dist: Lognormal\
  \ | Unit: USD | Click to view source\">$100B</a>"
"global_annual_environmental_damage_conflict_cite": "@environmental-cost-of-war"
"global_annual_human_cost_active_combat": "<a href=\"/knowledge/problem/cost-of-war#human-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#human-cost\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual cost of\
  \ combat deaths (deaths × VSL) | ✓ High confidence | Formula: COMBAT_DEATHS × VSL\
  \  | Unit: USD/year | Click to view calculation\">$2.34T</a>"
"global_annual_human_cost_active_combat_latex": "$$\nCost_{combat} = 233,600 \\times\
  \ \\$10M = \\$2,336B\n$$"
"global_annual_human_cost_state_violence": "<a href=\"/knowledge/problem/cost-of-war#human-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#human-cost\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual cost of\
  \ state violence deaths (deaths × VSL) | ✓ High confidence | Formula: STATE_DEATHS\
  \ × VSL  | Unit: USD/year | Click to view calculation\">$27B</a>"
"global_annual_human_cost_state_violence_latex": "$$\nCost_{state} = 2,700 \\times\
  \ \\$10M = \\$27B\n$$"
"global_annual_human_cost_terror_attacks": "<a href=\"/knowledge/problem/cost-of-war#human-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#human-cost\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual cost of\
  \ terror deaths (deaths × VSL) | ✓ High confidence | Formula: TERROR_DEATHS × VSL\
  \  | Unit: USD/year | Click to view calculation\">$83B</a>"
"global_annual_human_cost_terror_attacks_latex": "$$\nCost_{terror} = 8,300 \\times\
  \ \\$10M = \\$83B\n$$"
"global_annual_human_life_losses_conflict": "<a href=\"/knowledge/problem/cost-of-war#human-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#human-cost\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ human life losses from conflict (sum of combat, terror, state violence) | ✓ High\
  \ confidence | Formula: COMBAT_COST + TERROR_COST + STATE_VIOLENCE_COST | Unit:\
  \ USD/year | Click to view calculation\">$2.45T</a>"
"global_annual_human_life_losses_conflict_latex": "$$\nCost_{human} = \\$2,336B \\\
  text{ (combat)} + \\$83B \\text{ (terror)} + \\$27B \\text{ (state)} = \\$2,446B\n\
  $$"
"global_annual_infrastructure_damage_communications_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#environmental-cost-of-war\"\
  \ class=\"parameter-link\" data-source-ref=\"environmental-cost-of-war\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual infrastructure damage to communications\
  \ from conflict | ✓ High confidence | 95% CI: [$209B, $418B] | Dist: Lognormal |\
  \ Unit: USD | Click to view source\">$298B</a>"
"global_annual_infrastructure_damage_communications_conflict_cite": "@environmental-cost-of-war"
"global_annual_infrastructure_damage_education_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#environmental-cost-of-war\"\
  \ class=\"parameter-link\" data-source-ref=\"environmental-cost-of-war\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual infrastructure damage to education\
  \ facilities from conflict | ✓ High confidence | 95% CI: [$164B, $328B] | Dist:\
  \ Lognormal | Unit: USD | Click to view source\">$234B</a>"
"global_annual_infrastructure_damage_education_conflict_cite": "@environmental-cost-of-war"
"global_annual_infrastructure_damage_energy_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#environmental-cost-of-war\"\
  \ class=\"parameter-link\" data-source-ref=\"environmental-cost-of-war\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual infrastructure damage to energy\
  \ systems from conflict | ✓ High confidence | 95% CI: [$295B, $590B] | Dist: Lognormal\
  \ | Unit: USD | Click to view source\">$422B</a>"
"global_annual_infrastructure_damage_energy_conflict_cite": "@environmental-cost-of-war"
"global_annual_infrastructure_damage_healthcare_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#environmental-cost-of-war\"\
  \ class=\"parameter-link\" data-source-ref=\"environmental-cost-of-war\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual infrastructure damage to healthcare\
  \ facilities from conflict | ✓ High confidence | 95% CI: [$116B, $232B] | Dist:\
  \ Lognormal | Unit: USD | Click to view source\">$166B</a>"
"global_annual_infrastructure_damage_healthcare_conflict_cite": "@environmental-cost-of-war"
"global_annual_infrastructure_damage_transportation_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#environmental-cost-of-war\"\
  \ class=\"parameter-link\" data-source-ref=\"environmental-cost-of-war\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual infrastructure damage to transportation\
  \ from conflict | ✓ High confidence | 95% CI: [$340B, $680B] | Dist: Lognormal |\
  \ Unit: USD | Click to view source\">$487B</a>"
"global_annual_infrastructure_damage_transportation_conflict_cite": "@environmental-cost-of-war"
"global_annual_infrastructure_damage_water_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#environmental-cost-of-war\"\
  \ class=\"parameter-link\" data-source-ref=\"environmental-cost-of-war\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual infrastructure damage to water\
  \ systems from conflict | ✓ High confidence | 95% CI: [$187B, $375B] | Dist: Lognormal\
  \ | Unit: USD | Click to view source\">$268B</a>"
"global_annual_infrastructure_damage_water_conflict_cite": "@environmental-cost-of-war"
"global_annual_infrastructure_destruction_conflict": "<a href=\"/knowledge/problem/cost-of-war#infrastructure-damage\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#infrastructure-damage\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ infrastructure destruction (sum of transportation, energy, communications, water,\
  \ education, healthcare) | ✓ High confidence | Formula: TRANSPORT + ENERGY + COMMS\
  \ + WATER + EDUCATION + HEALTHCARE | Unit: USD/year | Click to view calculation\"\
  >$1.88T</a>"
"global_annual_infrastructure_destruction_conflict_latex": "$$\nInfra_{damage} = \\\
  $487B \\text{ (trans)} + \\$422B \\text{ (nrg)} + \\$298B \\text{ (comms)} + \\\
  $268B \\text{ (water)} + \\$235B \\text{ (edu)} + \\$166B \\text{ (hlth)} = \\$1,875B\n\
  $$"
"global_annual_lives_saved_by_med_research": "<a href=\"https://warondisease.org/knowledge/references.html#medical-research-lives-saved-annually\"\
  \ class=\"parameter-link\" data-source-ref=\"medical-research-lives-saved-annually\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual lives saved\
  \ by medical research globally | ✓ High confidence | 95% CI: [3.00M, 6.00M] | Dist:\
  \ Lognormal | Unit: lives/year | Click to view source\">4.20M</a>"
"global_annual_lives_saved_by_med_research_cite": "@medical-research-lives-saved-annually"
"global_annual_lost_economic_growth_military_spending": "<a href=\"https://warondisease.org/knowledge/references.html#disparity-ratio-weapons-vs-cures\"\
  \ class=\"parameter-link\" data-source-ref=\"disparity-ratio-weapons-vs-cures\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual lost economic\
  \ growth from military spending opportunity cost | ✓ High confidence | 95% CI: [$1.90T,\
  \ $3.80T] | Dist: Lognormal | Unit: USD | Click to view source\">$2.72T</a>"
"global_annual_lost_economic_growth_military_spending_cite": "@disparity-ratio-weapons-vs-cures"
"global_annual_lost_human_capital_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#lost-human-capital-war-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"lost-human-capital-war-cost\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual lost productivity from conflict\
  \ casualties | ✓ High confidence | 95% CI: [$210B, $420B] | Dist: Lognormal | Unit:\
  \ USD | Click to view source\">$300B</a>"
"global_annual_lost_human_capital_conflict_cite": "@lost-human-capital-war-cost"
"global_annual_psychological_impact_costs_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#psychological-impact-war-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"psychological-impact-war-cost\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual PTSD and mental health costs\
  \ from conflict | ✓ High confidence | 95% CI: [$162B, $325B] | Dist: Lognormal |\
  \ Unit: USD | Click to view source\">$232B</a>"
"global_annual_psychological_impact_costs_conflict_cite": "@psychological-impact-war-cost"
"global_annual_refugee_support_costs": "<a href=\"https://warondisease.org/knowledge/references.html#unhcr-refugee-support-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"unhcr-refugee-support-cost\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual refugee support costs (108.4M\
  \ refugees × $1,384/year) | ✓ High confidence | 95% CI: [$105B, $210B] | Dist: Lognormal\
  \ | Unit: USD | Click to view source\">$150B</a>"
"global_annual_refugee_support_costs_cite": "@unhcr-refugee-support-cost"
"global_annual_trade_disruption_conflict": "<a href=\"/knowledge/problem/cost-of-war#trade-disruption\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#trade-disruption\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ trade disruption (sum of shipping, supply chain, energy prices, currency instability)\
  \ | ✓ High confidence | Formula: SHIPPING + SUPPLY_CHAIN + ENERGY_PRICE + CURRENCY\
  \ | Unit: USD/year | Click to view calculation\">$616B</a>"
"global_annual_trade_disruption_conflict_latex": "$$\nTrade_{disruption} = \\$247B\
  \ \\text{ (ship)} + \\$187B \\text{ (supply)} + \\$125B \\text{ (nrg)} + \\$57B\
  \ \\text{ (curr)} = \\$616B\n$$"
"global_annual_trade_disruption_currency_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#world-bank-trade-disruption-conflict\"\
  \ class=\"parameter-link\" data-source-ref=\"world-bank-trade-disruption-conflict\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual trade disruption\
  \ costs from currency instability | ✓ High confidence | 95% CI: [$40B, $80B] | Dist:\
  \ Lognormal | Unit: USD | Click to view source\">$57.4B</a>"
"global_annual_trade_disruption_currency_conflict_cite": "@world-bank-trade-disruption-conflict"
"global_annual_trade_disruption_energy_price_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#world-bank-trade-disruption-conflict\"\
  \ class=\"parameter-link\" data-source-ref=\"world-bank-trade-disruption-conflict\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual trade disruption\
  \ costs from energy price volatility | ✓ High confidence | 95% CI: [$87B, $175B]\
  \ | Dist: Lognormal | Unit: USD | Click to view source\">$125B</a>"
"global_annual_trade_disruption_energy_price_conflict_cite": "@world-bank-trade-disruption-conflict"
"global_annual_trade_disruption_shipping_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#world-bank-trade-disruption-conflict\"\
  \ class=\"parameter-link\" data-source-ref=\"world-bank-trade-disruption-conflict\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual trade disruption\
  \ costs from shipping disruptions | ✓ High confidence | 95% CI: [$173B, $346B] |\
  \ Dist: Lognormal | Unit: USD | Click to view source\">$247B</a>"
"global_annual_trade_disruption_shipping_conflict_cite": "@world-bank-trade-disruption-conflict"
"global_annual_trade_disruption_supply_chain_conflict": "<a href=\"https://warondisease.org/knowledge/references.html#world-bank-trade-disruption-conflict\"\
  \ class=\"parameter-link\" data-source-ref=\"world-bank-trade-disruption-conflict\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual trade disruption\
  \ costs from supply chain disruptions | ✓ High confidence | 95% CI: [$131B, $262B]\
  \ | Dist: Lognormal | Unit: USD | Click to view source\">$187B</a>"
"global_annual_trade_disruption_supply_chain_conflict_cite": "@world-bank-trade-disruption-conflict"
"global_annual_veteran_healthcare_costs": "<a href=\"https://warondisease.org/knowledge/references.html#veteran-healthcare-cost-projections\"\
  \ class=\"parameter-link\" data-source-ref=\"veteran-healthcare-cost-projections\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual veteran\
  \ healthcare costs (20-year projected) | ✓ High confidence | 95% CI: [$140B, $280B]\
  \ | Dist: Lognormal | Unit: USD | Click to view source\">$200B</a>"
"global_annual_veteran_healthcare_costs_cite": "@veteran-healthcare-cost-projections"
"global_annual_war_direct_costs_total": "<a href=\"/knowledge/problem/cost-of-war#direct-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#direct-costs\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ direct war costs (military spending + infrastructure + human life + trade disruption)\
  \ | ✓ High confidence | Formula: MILITARY + INFRASTRUCTURE + HUMAN_LIFE + TRADE\
  \ | Unit: USD/year | Click to view calculation\">$7.66T</a>"
"global_annual_war_direct_costs_total_latex": "$$\nDirectCosts = \\$2,718B \\text{\
  \ (mil)} + \\$1,875B \\text{ (infra)} + \\$2,446B \\text{ (human)} + \\$616B \\\
  text{ (trade)} = \\$7,655B\n$$"
"global_annual_war_indirect_costs_total": "<a href=\"/knowledge/problem/cost-of-war#indirect-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#indirect-costs\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ indirect war costs (opportunity cost + veterans + refugees + environment + mental\
  \ health + lost productivity) | ✓ High confidence | Formula: OPPORTUNITY + VETERANS\
  \ + REFUGEES + ENVIRONMENT + MENTAL_HEALTH + LOST_CAPITAL | Unit: USD/year | Click\
  \ to view calculation\">$3.70T</a>"
"global_annual_war_indirect_costs_total_latex": "$$\nIndirectCosts = \\$2.7T \\text{\
  \ (opp cost)} + \\$200B \\text{ (vet)} + \\$150B \\text{ (ref)} + \\$100B \\text{\
  \ (env)} + \\$232B \\text{ (ptsd)} + \\$300B \\text{ (hum cap)} = \\$3.7T\n$$"
"global_annual_war_total_cost": "<a href=\"/knowledge/problem/cost-of-war#total-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#total-cost\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ cost of war worldwide (direct + indirect costs) | ✓ High confidence | Formula:\
  \ DIRECT_COSTS + INDIRECT_COSTS | Unit: USD/year | Click to view calculation\">$11.4T</a>"
"global_annual_war_total_cost_latex": "$$\nTotalWarCost = \\$7,655B \\text{ (direct)}\
  \ + \\$3,700B \\text{ (indirect)} = \\$11,355B\n$$"
"global_clinical_trials_spending_annual": "<a href=\"https://warondisease.org/knowledge/references.html#global-clinical-trials-market-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"global-clinical-trials-market-2024\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Annual global spending\
  \ on clinical trials | ✓ High confidence | 95% CI: [$70B, $97B] | Dist: Lognormal\
  \ (SE: $12.5B) | Unit: USD/year | Click to view source\">$83B</a>"
"global_clinical_trials_spending_annual_cite": "@global-clinical-trials-market-2024"
"global_cost_per_life_saved_med_research_annual": "<a href=\"/knowledge/problem/cost-of-war#grotesque-mathematics\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#grotesque-mathematics\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Cost per life\
  \ saved by medical research | ✓ High confidence | Formula: (RESEARCH_SPENDING ×\
  \ 1B) ÷ LIVES_SAVED | Unit: USD/life | Click to view calculation\">$16.1K</a>"
"global_cost_per_life_saved_med_research_annual_latex": "$$\nCostPerLifeSaved = \\\
  frac{\\$67.5B \\times 10^9}{4,200,000} \\approx \\$16,071\n$$"
"global_daily_deaths_curable_diseases": "<a href=\"https://warondisease.org/knowledge/references.html#deaths-from-treatable-diseases-15m\"\
  \ class=\"parameter-link\" data-source-ref=\"deaths-from-treatable-diseases-15m\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Daily deaths from\
  \ curable diseases globally | ✓ High confidence | 95% CI: [120K, 180K] | Dist: Lognormal\
  \ | Unit: deaths/day | Click to view source\">150K</a>"
"global_daily_deaths_curable_diseases_cite": "@deaths-from-treatable-diseases-15m"
"global_disease_deaths_daily": "<a href=\"https://warondisease.org/knowledge/references.html#who-global-health-estimates-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"who-global-health-estimates-2024\"\
  \ data-source-type=\"external\" data-peer-reviewed=\"true\" data-confidence=\"high\"\
  \ title=\"Total global deaths per day from all disease and aging (WHO Global Burden\
  \ of Disease 2024) | ✓ High confidence | \U0001F4CA Peer-reviewed | Unit: deaths/day\
  \ | Click to view source\">150K</a>"
"global_disease_deaths_daily_cite": "@who-global-health-estimates-2024"
"global_disease_direct_medical_cost_annual": "<a href=\"https://warondisease.org/knowledge/references.html#disease-economic-burden-109t\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-economic-burden-109t\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Direct medical costs of disease globally\
  \ (treatment, hospitalization, medication) | ✓ High confidence | 95% CI: [$7.00T,\
  \ $14T] | Dist: Lognormal | Unit: USD/year | Click to view source\">$9.90T</a>"
"global_disease_direct_medical_cost_annual_cite": "@disease-economic-burden-109t"
"global_disease_economic_burden_annual": "<a href=\"/disease-economic-burden-109t\"\
  \ class=\"parameter-link\" data-source-ref=\"/disease-economic-burden-109t\" data-source-type=\"\
  calculated\" data-confidence=\"high\" title=\"Total economic burden of disease globally\
  \ (medical + productivity + mortality) | ✓ High confidence | Formula: MEDICAL_COSTS\
  \ + PRODUCTIVITY_LOSS + MORTALITY_VALUE | Unit: USD/year | Click to view calculation\"\
  >$109T</a>"
"global_disease_economic_burden_annual_latex": "$$\nBurden_{annual} = \\$9.9T + \\\
  $5.0T + \\$94.2T = \\$109.1T\n$$"
"global_disease_human_life_value_loss_annual": "<a href=\"https://warondisease.org/knowledge/references.html#disease-economic-burden-109t\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-economic-burden-109t\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Economic value of human life lost to\
  \ disease annually (mortality valuation) | ✓ High confidence | 95% CI: [$66T, $132T]\
  \ | Dist: Lognormal | Unit: USD/year | Click to view source\">$94.2T</a>"
"global_disease_human_life_value_loss_annual_cite": "@disease-economic-burden-109t"
"global_disease_productivity_loss_annual": "<a href=\"https://warondisease.org/knowledge/references.html#disease-economic-burden-109t\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-economic-burden-109t\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual productivity loss from disease\
  \ globally (absenteeism, reduced output) | ✓ High confidence | 95% CI: [$3.50T,\
  \ $7.00T] | Dist: Lognormal | Unit: USD/year | Click to view source\">$5.00T</a>"
"global_disease_productivity_loss_annual_cite": "@disease-economic-burden-109t"
"global_life_expectancy_2024": "<a href=\"https://warondisease.org/knowledge/references.html#who-global-health-estimates-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"who-global-health-estimates-2024\"\
  \ data-source-type=\"external\" data-peer-reviewed=\"true\" data-confidence=\"high\"\
  \ title=\"Global life expectancy (2024) | ✓ High confidence | \U0001F4CA Peer-reviewed\
  \ | Dist: Normal (SE: 2) | Updated: 2024 | Unit: years | Click to view source\"\
  >79</a>"
"global_life_expectancy_2024_cite": "@who-global-health-estimates-2024"
"global_med_research_spending": "<a href=\"https://warondisease.org/knowledge/references.html#global-gov-med-research-spending\"\
  \ class=\"parameter-link\" data-source-ref=\"global-gov-med-research-spending\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Global government\
  \ medical research spending | ✓ High confidence | 95% CI: [$54B, $81B] | Dist: Lognormal\
  \ | Unit: USD | Click to view source\">$67.5B</a>"
"global_med_research_spending_cite": "@global-gov-med-research-spending"
"global_military_spending_annual_2024": "<a href=\"https://warondisease.org/knowledge/references.html#global-military-spending\"\
  \ class=\"parameter-link\" data-source-ref=\"global-military-spending\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Global military spending in 2024 | ✓\
  \ High confidence | 95% CI: [$2.45T, $2.99T] | Dist: Lognormal (SE: $272B) | Unit:\
  \ USD | Click to view source\">$2.72T</a>"
"global_military_spending_annual_2024_cite": "@global-military-spending"
"global_military_spending_per_capita_annual": "<a href=\"/knowledge/problem/cost-of-war#per-capita\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#per-capita\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Per capita military\
  \ spending globally | ✓ High confidence | Formula: MILITARY_SPENDING ÷ POPULATION\
  \ | Unit: USD/person/year | Click to view calculation\">$340</a>"
"global_military_spending_per_capita_annual_latex": "$$\nPerCapita_{military} = \\\
  $2,718B / 8.0B = \\$339.75\n$$"
"global_military_spending_post_treaty_annual_2024": "<a href=\"/knowledge/strategy/treaty-adoption-strategy#post-treaty\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/strategy/treaty-adoption-strategy.qmd#post-treaty\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Global military\
  \ spending after 1% treaty reduction | ✓ High confidence | Formula: MILITARY_SPENDING\
  \ × (1 - REDUCTION) | Unit: USD/year | Click to view calculation\">$2.69T</a>"
"global_military_spending_post_treaty_annual_2024_latex": "$$\nPostTreaty_{military}\
  \ = \\$2,718B \\times 0.99 = \\$2,690.82B\n$$"
"global_population_2024": "<a href=\"https://warondisease.org/knowledge/references.html#global-population-8-billion\"\
  \ class=\"parameter-link\" data-source-ref=\"global-population-8-billion\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Global population in 2024 | ✓ High confidence\
  \ | 95% CI: [7.80B, 8.20B] | Dist: Lognormal | Unit: of people | Click to view source\"\
  >8.00B</a>"
"global_population_2024_cite": "@global-population-8-billion"
"global_population_activism_threshold_pct": "<a href=\"https://warondisease.org/knowledge/references.html#3-5-rule\"\
  \ class=\"parameter-link\" data-source-ref=\"3-5-rule\" data-source-type=\"external\"\
  \ data-confidence=\"high\" title=\"Critical mass threshold for social change (3.5%\
  \ rule) | ✓ High confidence | 95% CI: [2.5%, 4.5%] | Dist: Lognormal | Unit: rate\
  \ | Click to view source\">3.5%</a>"
"global_population_activism_threshold_pct_cite": "@3-5-rule"
"global_symptomatic_disease_treatment_annual": "<a href=\"https://warondisease.org/knowledge/references.html#disease-economic-burden-109t\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-economic-burden-109t\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual global spending on symptomatic\
  \ disease treatment | ✓ High confidence | Unit: USD/year | Click to view source\"\
  >$8.20T</a>"
"global_symptomatic_disease_treatment_annual_cite": "@disease-economic-burden-109t"
"global_total_health_and_war_cost_annual": "<a href=\"/knowledge/appendix/humanity-budget-overview\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/humanity-budget-overview.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ cost of war and disease with all externalities (direct + indirect costs for both)\
  \ | ✓ High confidence | Formula: WAR_TOTAL_COSTS + SYMPTOMATIC_TREATMENT + DISEASE_BURDEN\
  \ | Unit: USD/year | Click to view calculation\">$129T</a>"
"historical_progress_deaths_total": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#historical-progress\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#historical-progress\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total deaths\
  \ from delaying existing drugs over 8.2-year efficacy lag (CONSERVATIVE FLOOR).\
  \ One-time impact of eliminating Phase 2-4 testing delay for drugs already approved\
  \ 1962-2024. Based on 12M deaths/year rate × 8.2 years. | ✓ High confidence | Formula:\
  \ 12M × EFFICACY_LAG_YEARS | Unit: deaths | Click to view calculation\">98.4M</a>"
"historical_progress_deaths_total_latex": "$$\nD_{total} = 12M \\times 8.2 = 98.4M\n\
  $$"
"historical_progress_economic_loss_total": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#historical-progress\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#historical-progress\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total economic\
  \ loss from delaying existing drugs over 8.2-year efficacy lag (CONSERVATIVE FLOOR).\
  \ One-time benefit of eliminating Phase 2-4 delay. | ✓ High confidence | Formula:\
  \ DEATHS_TOTAL × YLL × VSLY | Unit: USD | Click to view calculation\">$251T</a>"
"historical_progress_economic_loss_total_latex": "$$\nLoss_{total} = 98.4M \\times\
  \ 17 \\times \\$150k = \\$251T\n$$"
"human_genome_project_total_economic_impact": "<a href=\"https://warondisease.org/knowledge/references.html#human-genome-and-genetic-editing\"\
  \ class=\"parameter-link\" data-source-ref=\"human-genome-and-genetic-editing\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Estimated total\
  \ economic impact of Human Genome Project | ✓ High confidence | Unit: USD | Click\
  \ to view source\">$1.00T</a>"
"human_genome_project_total_economic_impact_cite": "@human-genome-and-genetic-editing"
"infections_death_rate": "<span class=\"parameter-link\" title=\"parameters.INFECTIONS_DEATH_RATE\
  \ - Estimate (flu, pneumonia, sepsis)\">15</span>"
"institutional_investor_min": "<a href=\"/knowledge/economics/victory-bonds\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/victory-bonds.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Minimum investment for institutional\
  \ investors | ✓ High confidence | Unit: USD | Click to view calculation\">$10M</a>"
"life_extension_years_10pct": "<span class=\"parameter-link\" title=\"parameters.LIFE_EXTENSION_YEARS_10PCT\"\
  >2.57</span>"
"life_extension_years_1pct": "<span class=\"parameter-link\" title=\"parameters.LIFE_EXTENSION_YEARS_1PCT\"\
  >0.257</span>"
"life_extension_years_2pct": "<span class=\"parameter-link\" title=\"parameters.LIFE_EXTENSION_YEARS_2PCT\"\
  >0.514</span>"
"life_extension_years_5pct": "<span class=\"parameter-link\" title=\"parameters.LIFE_EXTENSION_YEARS_5PCT\"\
  >1.29</span>"
"lobbyist_bond_investment_max": "<a href=\"/knowledge/strategy/roadmap#lobbyist-incentives\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/strategy/roadmap.qmd#lobbyist-incentives\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Maximum bond\
  \ investment for lobbyist incentives | ✓ High confidence | Unit: USD | Click to\
  \ view calculation\">$20M</a>"
"lobbyist_salary_max": "<a href=\"https://warondisease.org/knowledge/references.html#lobbyist-statistics-dc\"\
  \ class=\"parameter-link\" data-source-ref=\"lobbyist-statistics-dc\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Maximum annual lobbyist salary range\
  \ | ✓ High confidence | Unit: USD | Click to view source\">$2.00M</a>"
"lobbyist_salary_max_cite": "@lobbyist-statistics-dc"
"lobbyist_salary_min_k": "<a href=\"https://warondisease.org/knowledge/references.html#lobbyist-statistics-dc\"\
  \ class=\"parameter-link\" data-source-ref=\"lobbyist-statistics-dc\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Minimum annual lobbyist salary range\
  \ | ✓ High confidence | Unit: USD | Click to view source\">$500K</a>"
"lobbyist_salary_min_k_cite": "@lobbyist-statistics-dc"
"measles_vaccination_roi": "<a href=\"https://warondisease.org/knowledge/references.html#measles-vaccination-roi\"\
  \ class=\"parameter-link\" data-source-ref=\"measles-vaccination-roi\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Return on investment from measles (MMR)\
  \ vaccination programs | ✓ High confidence | Unit: ratio | Click to view source\"\
  >14</a>"
"measles_vaccination_roi_cite": "@measles-vaccination-roi"
"medical_research_pct_of_disease_burden": "<a href=\"/knowledge/economics/economics\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Medical research\
  \ spending as percentage of total disease burden | ✓ High confidence | Formula:\
  \ MED_RESEARCH ÷ TOTAL_BURDEN | Unit: rate | Click to view calculation\">0.0525%</a>"
"medical_research_pct_of_disease_burden_latex": "$$\n\\frac{\\$67.5\\text{B}}{\\$128.6\\\
  text{T}} = 0.052\\%\n$$"
"mental_health_productivity_loss_per_capita": "<a href=\"https://warondisease.org/knowledge/references.html#mental-health-burden\"\
  \ class=\"parameter-link\" data-source-ref=\"mental-health-burden\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual productivity loss per capita\
  \ from mental health issues (beyond treatment costs) | ✓ High confidence | Unit:\
  \ USD/year | Click to view source\">$2.00K</a>"
"mental_health_productivity_loss_per_capita_cite": "@mental-health-burden"
"military_vs_medical_research_ratio": "<a href=\"/knowledge/problem/cost-of-war#misallocation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#misallocation\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Ratio of military\
  \ spending to medical research spending | ✓ High confidence | Formula: MILITARY_SPENDING\
  \ ÷ MEDICAL_RESEARCH | Unit: ratio | Click to view calculation\">40.3</a>"
"military_vs_medical_research_ratio_latex": "$$\nRatio = \\frac{\\$2,718B}{\\$67.5B}\
  \ \\approx 40.3:1\n$$"
"misallocation_factor_death_vs_saving": "<a href=\"/knowledge/problem/cost-of-war#grotesque-mathematics\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/problem/cost-of-war.qmd#grotesque-mathematics\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Misallocation\
  \ factor: cost to kill vs cost to save | ✓ High confidence | Formula: COST_PER_DEATH\
  \ ÷ COST_PER_LIFE_SAVED | Unit: ratio | Click to view calculation\">2,889</a>"
"misallocation_factor_death_vs_saving_latex": "$$\nMisallocation = \\frac{\\$46.4M}{\\\
  $16,071} \\approx 2,889x\n$$"
"npv_discount_rate_standard": "<span class=\"parameter-definition\" title=\"Standard\
  \ discount rate for NPV analysis (8% annual) | Unit: rate | Core definition\">8%</span>"
"npv_discount_rate_standard_latex": "$$\nr = 0.08 \\text{ (discount rate)}\n$$"
"npv_time_horizon_years": "<span class=\"parameter-definition\" title=\"Standard time\
  \ horizon for NPV analysis | Unit: years | Core definition\">10</span>"
"npv_time_horizon_years_latex": "$$\nT = 10 \\text{ (time horizon, years)}\n$$"
"oxford_recovery_trial_duration_months": "<a href=\"https://warondisease.org/knowledge/references.html#recovery-trial-82x-cost-reduction\"\
  \ class=\"parameter-link\" data-source-ref=\"recovery-trial-82x-cost-reduction\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Oxford RECOVERY\
  \ trial duration (found life-saving treatment in 3 months) | ✓ High confidence |\
  \ Unit: months | Click to view source\">3</a>"
"oxford_recovery_trial_duration_months_cite": "@recovery-trial-82x-cost-reduction"
"patient_willingness_trial_participation_pct": "<a href=\"https://warondisease.org/knowledge/references.html#patient-willingness-clinical-trials\"\
  \ class=\"parameter-link\" data-source-ref=\"patient-willingness-clinical-trials\"\
  \ data-source-type=\"external\" data-confidence=\"medium\" title=\"Patient willingness\
  \ to participate in drug trials (44.8% in surveys, 88% when actually approached)\
  \ | ~ Medium confidence | Unit: percentage | Click to view source\">44.8%</a>"
"patient_willingness_trial_participation_pct_cite": "@patient-willingness-clinical-trials"
"peace_dividend_annual_societal_benefit": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness#peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#peace-dividend\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual peace\
  \ dividend from 1% reduction in total war costs | ✓ High confidence | Formula: TOTAL_WAR_COST\
  \ × 1% | Unit: USD/year | Click to view calculation\">$114B</a>"
"peace_dividend_annual_societal_benefit_latex": "$$\nPeaceDividend = \\$11,355B \\\
  times 0.01 = \\$113.55B\n$$"
"peace_dividend_conflict_reduction": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ data-source-ref=\"/calculated\" data-source-type=\"calculated\" data-confidence=\"\
  low\" title=\"Conflict reduction benefits from 1% less military spending (lower\
  \ confidence - assumes proportional relationship) | ? Low confidence | Formula:\
  \ PEACE_DIVIDEND_ANNUAL_SOCIETAL_BENEFIT - TREATY_ANNUAL_FUNDING | Unit: USD/year\
  \ | Click to view calculation\">$86.4B</a>"
"peace_dividend_conflict_reduction_latex": "$$\nPeaceDividend_{conflict} = \\$113.55B\
  \ - \\$27.18B = \\$86.37B\n$$"
"peace_dividend_direct_costs": "<a href=\"/knowledge/economics/peace-dividend\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\" data-source-type=\"\
  calculated\" data-confidence=\"high\" title=\"Annual savings from 1% reduction in\
  \ direct war costs | ✓ High confidence | Formula: DIRECT_COSTS × 1% | Unit: USD/year\
  \ | Click to view calculation\">$76.5B</a>"
"peace_dividend_direct_costs_latex": "$$\nPeaceDividend_{direct} = \\$7,655B \\times\
  \ 0.01 = \\$76.55B\n$$"
"peace_dividend_direct_fiscal_savings": "<a href=\"/sipri-2024-spending\" class=\"\
  parameter-link\" data-source-ref=\"/sipri-2024-spending\" data-source-type=\"definition\"\
  \ data-confidence=\"high\" title=\"Direct fiscal savings from 1% military spending\
  \ reduction (high confidence) | ✓ High confidence | Formula: TREATY_ANNUAL_FUNDING\
  \ | Unit: USD/year | Click to view calculation\">$27.2B</a>"
"peace_dividend_direct_fiscal_savings_latex": "$$\nPeaceDividend_{fiscal} = \\$27.18B\n\
  $$"
"peace_dividend_environmental": "<a href=\"/knowledge/economics/peace-dividend\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\" data-source-type=\"\
  calculated\" data-confidence=\"high\" title=\"Annual savings from 1% reduction in\
  \ environmental damage | ✓ High confidence | Formula: ENVIRONMENTAL_DAMAGE × 1%\
  \ | Unit: USD/year | Click to view calculation\">$1.00B</a>"
"peace_dividend_environmental_latex": "$$\nPeaceDividend_{env} = \\$10B \\times 0.01\
  \ = \\$0.10B\n$$"
"peace_dividend_human_casualties": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in human casualties | ✓ High confidence | Formula: HUMAN_LIFE_LOSSES\
  \ × 1% | Unit: USD/year | Click to view calculation\">$24.5B</a>"
"peace_dividend_human_casualties_latex": "$$\nPeaceDividend_{human} = \\$2,446B \\\
  times 0.01 = \\$24.46B\n$$"
"peace_dividend_indirect_costs": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in indirect war costs | ✓ High confidence | Formula: INDIRECT_COSTS\
  \ × 1% | Unit: USD/year | Click to view calculation\">$37B</a>"
"peace_dividend_indirect_costs_latex": "$$\nPeaceDividend_{indirect} = \\$3,700.1B\
  \ \\times 0.01 = \\$37.00B\n$$"
"peace_dividend_infrastructure": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in infrastructure destruction | ✓ High confidence | Formula:\
  \ INFRASTRUCTURE_DESTRUCTION × 1% | Unit: USD/year | Click to view calculation\"\
  >$18.8B</a>"
"peace_dividend_infrastructure_latex": "$$\nPeaceDividend_{infra} = \\$1,875B \\times\
  \ 0.01 = \\$18.75B\n$$"
"peace_dividend_lost_economic_growth": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in lost economic growth | ✓ High confidence | Formula: LOST_ECONOMIC_GROWTH\
  \ × 1% | Unit: USD/year | Click to view calculation\">$27.2B</a>"
"peace_dividend_lost_economic_growth_latex": "$$\nPeaceDividend_{growth} = \\$2,718B\
  \ \\times 0.01 = \\$27.18B\n$$"
"peace_dividend_lost_human_capital": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in lost human capital | ✓ High confidence | Formula: LOST_HUMAN_CAPITAL\
  \ × 1% | Unit: USD/year | Click to view calculation\">$3.00B</a>"
"peace_dividend_lost_human_capital_latex": "$$\nPeaceDividend_{capital} = \\$30B \\\
  times 0.01 = \\$0.30B\n$$"
"peace_dividend_ptsd": "<a href=\"/knowledge/economics/peace-dividend\" class=\"parameter-link\"\
  \ data-source-ref=\"/knowledge/economics/peace-dividend.qmd\" data-source-type=\"\
  calculated\" data-confidence=\"high\" title=\"Annual savings from 1% reduction in\
  \ PTSD and mental health costs | ✓ High confidence | Formula: PTSD_COSTS × 1% |\
  \ Unit: USD/year | Click to view calculation\">$2.32B</a>"
"peace_dividend_ptsd_latex": "$$\nPeaceDividend_{PTSD} = \\$23.2B \\times 0.01 = \\\
  $0.23B\n$$"
"peace_dividend_refugee_support": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in refugee support costs | ✓ High confidence | Formula: REFUGEE_SUPPORT\
  \ × 1% | Unit: USD/year | Click to view calculation\">$1.50B</a>"
"peace_dividend_refugee_support_latex": "$$\nPeaceDividend_{refugee} = \\$15B \\times\
  \ 0.01 = \\$0.15B\n$$"
"peace_dividend_trade_disruption": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in trade disruption | ✓ High confidence | Formula: TRADE_DISRUPTION\
  \ × 1% | Unit: USD/year | Click to view calculation\">$6.16B</a>"
"peace_dividend_trade_disruption_latex": "$$\nPeaceDividend_{trade} = \\$616B \\times\
  \ 0.01 = \\$6.16B\n$$"
"peace_dividend_veteran_healthcare": "<a href=\"/knowledge/economics/peace-dividend\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/peace-dividend.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual savings\
  \ from 1% reduction in veteran healthcare costs | ✓ High confidence | Formula: VETERAN_HEALTHCARE\
  \ × 1% | Unit: USD/year | Click to view calculation\">$2.00B</a>"
"peace_dividend_veteran_healthcare_latex": "$$\nPeaceDividend_{veteran} = \\$20.01B\
  \ \\times 0.01 = \\$0.20B\n$$"
"personal_lifetime_benefit_age_20_1pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_20_1PCT\">205K</span>"
"personal_lifetime_benefit_age_30_10pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_30_10PCT\">2.55M</span>"
"personal_lifetime_benefit_age_30_1pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_30_1PCT\">186K</span>"
"personal_lifetime_benefit_age_30_2pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_30_2PCT\">390K</span>"
"personal_lifetime_benefit_age_30_5pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_30_5PCT\">1.12M</span>"
"personal_lifetime_benefit_age_30_half_pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_30_HALF_PCT\">91,034</span>"
"personal_lifetime_benefit_age_40_1pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_40_1PCT\">153K</span>"
"personal_lifetime_benefit_age_50_1pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_50_1PCT\">104K</span>"
"personal_lifetime_benefit_age_60_1pct": "<span class=\"parameter-link\" title=\"\
  parameters.PERSONAL_LIFETIME_BENEFIT_AGE_60_1PCT\">51,902</span>"
"personal_lifetime_benefit_conservative_age_30_1pct": "<span class=\"parameter-link\"\
  \ title=\"parameters.PERSONAL_LIFETIME_BENEFIT_CONSERVATIVE_AGE_30_1PCT\">186K</span>"
"personal_lifetime_benefit_conservative_moderate_age_30_1pct": "<span class=\"parameter-link\"\
  \ title=\"parameters.PERSONAL_LIFETIME_BENEFIT_CONSERVATIVE_MODERATE_AGE_30_1PCT\"\
  >208K</span>"
"personal_lifetime_benefit_eradication_10yr_age_30_1pct": "<span class=\"parameter-link\"\
  \ title=\"parameters.PERSONAL_LIFETIME_BENEFIT_ERADICATION_10YR_AGE_30_1PCT\">687K</span>"
"personal_lifetime_benefit_eradication_20yr_age_30_1pct": "<span class=\"parameter-link\"\
  \ title=\"parameters.PERSONAL_LIFETIME_BENEFIT_ERADICATION_20YR_AGE_30_1PCT\">848K</span>"
"personal_lifetime_benefit_eradication_40yr_age_30_1pct": "<span class=\"parameter-link\"\
  \ title=\"parameters.PERSONAL_LIFETIME_BENEFIT_ERADICATION_40YR_AGE_30_1PCT\">1.04M</span>"
"personal_lifetime_benefit_eradication_5yr_age_30_1pct": "<span class=\"parameter-link\"\
  \ title=\"parameters.PERSONAL_LIFETIME_BENEFIT_ERADICATION_5YR_AGE_30_1PCT\">572K</span>"
"per_capita_chronic_disease_cost": "<span class=\"parameter-link\" title=\"parameters.PER_CAPITA_CHRONIC_DISEASE_COST\"\
  >$12.2K</span>"
"per_capita_mental_health_cost": "<span class=\"parameter-link\" title=\"parameters.PER_CAPITA_MENTAL_HEALTH_COST\"\
  >$1.04K</span>"
"pharma_drug_development_cost_current": "<a href=\"https://warondisease.org/knowledge/references.html#drug-development-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"drug-development-cost\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Average\
  \ cost to develop one drug in current system | ✓ High confidence | \U0001F4CA Peer-reviewed\
  \ | 95% CI: [$1.50B, $4.00B] | Dist: Lognormal (SE: $500M) | Unit: USD | Click to\
  \ view source\">$2.60B</a>"
"pharma_drug_development_cost_current_cite": "@drug-development-cost"
"pharma_drug_revenue_average_current": "<a href=\"https://warondisease.org/knowledge/references.html#pharma-drug-revenue-average\"\
  \ class=\"parameter-link\" data-source-ref=\"pharma-drug-revenue-average\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Median lifetime\
  \ revenue per successful drug (study of 361 FDA-approved drugs 1995-2014, median\
  \ follow-up 13.2 years) | ✓ High confidence | \U0001F4CA Peer-reviewed | Unit: USD\
  \ | Click to view source\">$6.70B</a>"
"pharma_drug_revenue_average_current_cite": "@pharma-drug-revenue-average"
"pharma_roi_current_system_pct": "<a href=\"https://warondisease.org/knowledge/references.html#pharma-roi-current\"\
  \ class=\"parameter-link\" data-source-ref=\"pharma-roi-current\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"ROI for\
  \ pharma R&D (2022 historic low from Deloitte study of top 20 pharma companies,\
  \ down from 6.8% in 2021, recovered to 5.9% in 2024) | ✓ High confidence | \U0001F4CA\
  \ Peer-reviewed | Unit: percentage | Click to view source\">1.2%</a>"
"pharma_roi_current_system_pct_cite": "@pharma-roi-current"
"pharma_success_rate_current_pct": "<a href=\"https://warondisease.org/knowledge/references.html#drug-trial-success-rate-12-pct\"\
  \ class=\"parameter-link\" data-source-ref=\"drug-trial-success-rate-12-pct\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Percentage\
  \ of drugs that reach market in current system | ✓ High confidence | \U0001F4CA\
  \ Peer-reviewed | Unit: percentage | Click to view source\">10%</a>"
"pharma_success_rate_current_pct_cite": "@drug-trial-success-rate-12-pct"
"phase_1_safety_duration_years": "<a href=\"https://warondisease.org/knowledge/references.html#bio-clinical-development-2021\"\
  \ class=\"parameter-link\" data-source-ref=\"bio-clinical-development-2021\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Phase I\
  \ safety trial duration | ✓ High confidence | \U0001F4CA Peer-reviewed | Updated:\
  \ 2021 | Unit: years | Click to view source\">2.3</a>"
"phase_1_safety_duration_years_cite": "@bio-clinical-development-2021"
"phase_3_trial_cost_min": "<a href=\"https://warondisease.org/knowledge/references.html#phase-3-cost-per-trial-range\"\
  \ class=\"parameter-link\" data-source-ref=\"phase-3-cost-per-trial-range\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Phase 3 trial total cost (minimum) |\
  \ ✓ High confidence | Unit: USD/trial | Click to view source\">$20M</a>"
"phase_3_trial_cost_min_cite": "@phase-3-cost-per-trial-range"
"polio_vaccination_roi": "<a href=\"https://warondisease.org/knowledge/references.html#polio-vaccination-roi\"\
  \ class=\"parameter-link\" data-source-ref=\"polio-vaccination-roi\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Return on investment from sustaining\
  \ polio vaccination assets and integrating into expanded immunization programs |\
  \ ✓ High confidence | Unit: ratio | Click to view source\">39</a>"
"polio_vaccination_roi_cite": "@polio-vaccination-roi"
"political_success_probability_conservative": "<a href=\"https://warondisease.org/knowledge/references.html#icbl-ottawa-treaty\"\
  \ class=\"parameter-link\" data-source-ref=\"icbl-ottawa-treaty\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Conservative estimate of political\
  \ success probability (10%) | ~ Medium confidence | Click to view source\">0.1</a>"
"political_success_probability_conservative_cite": "@icbl-ottawa-treaty"
"political_success_probability_extremely_pessimistic": "<a href=\"https://warondisease.org/knowledge/references.html#icbl-ottawa-treaty\"\
  \ class=\"parameter-link\" data-source-ref=\"icbl-ottawa-treaty\" data-source-type=\"\
  external\" data-confidence=\"low\" title=\"Extremely pessimistic estimate of political\
  \ success probability (0.1%) | ? Low confidence | Click to view source\">0.001</a>"
"political_success_probability_extremely_pessimistic_cite": "@icbl-ottawa-treaty"
"political_success_probability_moderate": "<a href=\"https://warondisease.org/knowledge/references.html#icbl-ottawa-treaty\"\
  \ class=\"parameter-link\" data-source-ref=\"icbl-ottawa-treaty\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Moderate estimate of political success\
  \ probability (25%) | ~ Medium confidence | Click to view source\">0.25</a>"
"political_success_probability_moderate_cite": "@icbl-ottawa-treaty"
"political_success_probability_moderate_high": "<a href=\"https://warondisease.org/knowledge/references.html#icbl-ottawa-treaty\"\
  \ class=\"parameter-link\" data-source-ref=\"icbl-ottawa-treaty\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Moderate-high estimate of political\
  \ success probability (40%) | ~ Medium confidence | Click to view source\">0.4</a>"
"political_success_probability_moderate_high_cite": "@icbl-ottawa-treaty"
"political_success_probability_optimistic": "<a href=\"https://warondisease.org/knowledge/references.html#icbl-ottawa-treaty\"\
  \ class=\"parameter-link\" data-source-ref=\"icbl-ottawa-treaty\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Optimistic estimate of political success\
  \ probability (50%) | ~ Medium confidence | Click to view source\">0.5</a>"
"political_success_probability_optimistic_cite": "@icbl-ottawa-treaty"
"political_success_probability_very_pessimistic": "<a href=\"https://warondisease.org/knowledge/references.html#icbl-ottawa-treaty\"\
  \ class=\"parameter-link\" data-source-ref=\"icbl-ottawa-treaty\" data-source-type=\"\
  external\" data-confidence=\"low\" title=\"Very pessimistic estimate of political\
  \ success probability (1%) | ? Low confidence | Click to view source\">0.01</a>"
"political_success_probability_very_pessimistic_cite": "@icbl-ottawa-treaty"
"post_1962_drug_approval_reduction_pct": "<a href=\"https://warondisease.org/knowledge/references.html#post-1962-drug-approval-drop\"\
  \ class=\"parameter-link\" data-source-ref=\"post-1962-drug-approval-drop\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Reduction in new drug approvals after\
  \ 1962 Kefauver-Harris Amendment (70% drop from 43→17 drugs/year) | ✓ High confidence\
  \ | Updated: 1962-1970 | Unit: percentage | Click to view source\">70%</a>"
"post_1962_drug_approval_reduction_pct_cite": "@post-1962-drug-approval-drop"
"post_ww2_military_cut_pct": "<a href=\"https://warondisease.org/knowledge/references.html#us-post-wwii-military-spending-cut\"\
  \ class=\"parameter-link\" data-source-ref=\"us-post-wwii-military-spending-cut\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Percentage military\
  \ spending cut after WW2 (historical precedent) | ✓ High confidence | Unit: rate\
  \ | Click to view source\">30%</a>"
"post_ww2_military_cut_pct_cite": "@us-post-wwii-military-spending-cut"
"pre_1962_drug_development_cost": "<a href=\"https://warondisease.org/knowledge/references.html#pre-1962-drug-costs-timeline\"\
  \ class=\"parameter-link\" data-source-ref=\"pre-1962-drug-costs-timeline\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Pre-1962 drug development cost (documented\
  \ range: $10-50M in 1950s-1960s) | ~ Medium confidence | Unit: USD | Click to view\
  \ source\">$50M</a>"
"pre_1962_drug_development_cost_cite": "@pre-1962-drug-costs-timeline"
"pre_1962_physician_count": "<a href=\"https://warondisease.org/knowledge/references.html#pre-1962-physician-trials\"\
  \ class=\"parameter-link\" data-source-ref=\"pre-1962-physician-trials\" data-source-type=\"\
  external\" data-confidence=\"low\" title=\"Estimated physicians conducting real-world\
  \ efficacy trials pre-1962 (unverified estimate) | ? Low confidence | Unit: physicians\
  \ | Click to view source\">144K</a>"
"pre_1962_physician_count_cite": "@pre-1962-physician-trials"
"pre_1962_validation_years": "<a href=\"/life-expectancy-increase-pre-1962\" class=\"\
  parameter-link\" data-source-ref=\"/life-expectancy-increase-pre-1962\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Years of empirical validation for\
  \ physician-led pragmatic trials (1883-1960) | ✓ High confidence | Formula: 1960\
  \ - 1883 | Unit: years | Click to view calculation\">77</a>"
"rare_diseases_count_global": "<a href=\"https://warondisease.org/knowledge/references.html#95-pct-diseases-no-treatment\"\
  \ class=\"parameter-link\" data-source-ref=\"95-pct-diseases-no-treatment\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Total number of rare diseases globally\
  \ | ✓ High confidence | Unit: diseases | Click to view source\">7,000</a>"
"rare_diseases_count_global_cite": "@95-pct-diseases-no-treatment"
"recovery_trial_cost_per_patient": "<a href=\"https://warondisease.org/knowledge/references.html#recovery-cost-500\"\
  \ class=\"parameter-link\" data-source-ref=\"recovery-cost-500\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"RECOVERY trial cost per patient | ✓\
  \ High confidence | 95% CI: [$350, $700] | Dist: Lognormal | Unit: USD/patient |\
  \ Click to view source\">$500</a>"
"recovery_trial_cost_per_patient_cite": "@recovery-cost-500"
"regulatory_delay_mean_age_of_death": "<a href=\"https://warondisease.org/knowledge/references.html#who-global-health-estimates-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"who-global-health-estimates-2024\"\
  \ data-source-type=\"external\" data-peer-reviewed=\"true\" data-confidence=\"medium\"\
  \ title=\"Mean age of preventable death from post-safety efficacy testing regulatory\
  \ delay (Phase 2-4) | ~ Medium confidence | \U0001F4CA Peer-reviewed | Dist: Normal\
  \ (SE: 3) | Unit: years | Click to view source\">62</a>"
"regulatory_delay_mean_age_of_death_cite": "@who-global-health-estimates-2024"
"regulatory_delay_suffering_period_years": "<a href=\"https://warondisease.org/knowledge/references.html#who-global-health-estimates-2024\"\
  \ class=\"parameter-link\" data-source-ref=\"who-global-health-estimates-2024\"\
  \ data-source-type=\"external\" data-peer-reviewed=\"true\" data-confidence=\"medium\"\
  \ title=\"Pre-death suffering period during post-safety efficacy testing delay (average\
  \ years lived with untreated condition while awaiting Phase 2-4 completion) | ~\
  \ Medium confidence | \U0001F4CA Peer-reviewed | 95% CI: [4, 9] | Dist: Lognormal\
  \ | Unit: years | Click to view source\">6</a>"
"regulatory_delay_suffering_period_years_cite": "@who-global-health-estimates-2024"
"roi_discount_1pct": "<a href=\"/calculated\" class=\"parameter-link\" data-source-ref=\"\
  /calculated\" data-source-type=\"calculated\" data-confidence=\"medium\" title=\"\
  ROI at 1% discount rate (approximate 15% increase from 3% baseline) | ~ Medium confidence\
  \ | Formula: DFDA_ROI_RD_ONLY * 1.15 | Click to view calculation\">442</a>"
"roi_discount_1pct_latex": "$$\nROI_{1\\%} \\approx 463 \\times 1.15 = 532\n$$"
"roi_discount_3pct": "<a href=\"/calculated\" class=\"parameter-link\" data-source-ref=\"\
  /calculated\" data-source-type=\"calculated\" data-confidence=\"high\" title=\"\
  ROI at 3% discount rate (baseline) | ✓ High confidence | Formula: DFDA_ROI_RD_ONLY\
  \ | Click to view calculation\">384</a>"
"roi_discount_3pct_latex": "$$\nROI_{3\\%} = 463\n$$"
"roi_discount_5pct": "<a href=\"/calculated\" class=\"parameter-link\" data-source-ref=\"\
  /calculated\" data-source-type=\"calculated\" data-confidence=\"medium\" title=\"\
  ROI at 5% discount rate (approximate 12% decrease from 3% baseline) | ~ Medium confidence\
  \ | Formula: DFDA_ROI_RD_ONLY * 0.88 | Click to view calculation\">338</a>"
"roi_discount_5pct_latex": "$$\nROI_{5\\%} \\approx 463 \\times 0.88 = 407\n$$"
"roi_discount_7pct": "<a href=\"/calculated\" class=\"parameter-link\" data-source-ref=\"\
  /calculated\" data-source-type=\"calculated\" data-confidence=\"medium\" title=\"\
  ROI at 7% discount rate (approximate 22% decrease from 3% baseline) | ~ Medium confidence\
  \ | Formula: DFDA_ROI_RD_ONLY * 0.78 | Click to view calculation\">300</a>"
"roi_discount_7pct_latex": "$$\nROI_{7\\%} \\approx 463 \\times 0.78 = 361\n$$"
"seconds_per_year": "<span class=\"parameter-link\" title=\"parameters.SECONDS_PER_YEAR\"\
  >31.5M</span>"
"smallpox_eradication_roi": "<a href=\"https://warondisease.org/knowledge/references.html#smallpox-eradication-roi\"\
  \ class=\"parameter-link\" data-source-ref=\"smallpox-eradication-roi\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Return on investment from smallpox eradication\
  \ campaign | ✓ High confidence | Unit: ratio | Click to view source\">280</a>"
"smallpox_eradication_roi_cite": "@smallpox-eradication-roi"
"smallpox_eradication_total_benefit": "<a href=\"https://warondisease.org/knowledge/references.html#smallpox-eradication-roi\"\
  \ class=\"parameter-link\" data-source-ref=\"smallpox-eradication-roi\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Total economic benefit from smallpox\
  \ eradication campaign | ✓ High confidence | Unit: USD | Click to view source\"\
  >$1.42B</a>"
"smallpox_eradication_total_benefit_cite": "@smallpox-eradication-roi"
"smoking_cessation_annual_benefit": "<a href=\"https://warondisease.org/knowledge/references.html#life-expectancy-gains-smoking-reduction\"\
  \ class=\"parameter-link\" data-source-ref=\"life-expectancy-gains-smoking-reduction\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Estimated annual\
  \ global economic benefit from smoking cessation programs | ✓ High confidence |\
  \ Unit: USD/year | Click to view source\">$12B</a>"
"smoking_cessation_annual_benefit_cite": "@life-expectancy-gains-smoking-reduction"
"standard_economic_qaly_value_usd": "<a href=\"https://warondisease.org/knowledge/references.html#qaly-value\"\
  \ class=\"parameter-link\" data-source-ref=\"qaly-value\" data-source-type=\"external\"\
  \ data-confidence=\"high\" title=\"Standard economic value per QALY | ✓ High confidence\
  \ | Dist: Normal (SE: $30K) | Unit: USD/QALY | Click to view source\">$150K</a>"
"standard_economic_qaly_value_usd_cite": "@qaly-value"
"standard_qalys_per_life_saved": "<a href=\"https://warondisease.org/knowledge/references.html#qaly-value\"\
  \ class=\"parameter-link\" data-source-ref=\"qaly-value\" data-source-type=\"external\"\
  \ data-confidence=\"high\" title=\"Standard QALYs per life saved (WHO life tables)\
  \ | ✓ High confidence | Unit: QALYs/life | Click to view source\">35</a>"
"standard_qalys_per_life_saved_cite": "@qaly-value"
"suffering_hours_eliminated_total": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#daly-calculation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#daly-calculation\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Total hours\
  \ of human suffering eliminated by 8.2-year disease eradication timeline shift (one-time\
  \ benefit from YLD component, not annual recurring) | ~ Medium confidence | Formula:\
  \ YLD × 8760 hours/year | Unit: hours | Click to view calculation\">7.65T</a>"
"suffering_hours_eliminated_total_latex": "$$\nHours = 868M \\text{ (YLD)} \\times\
  \ 8{,}760 \\text{ (hrs/yr)} = 7.60T\n$$"
"sugar_subsidy_cost_per_person_annual": "<a href=\"https://warondisease.org/knowledge/references.html#sugar-subsidies-cost\"\
  \ class=\"parameter-link\" data-source-ref=\"sugar-subsidies-cost\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Annual cost of sugar subsidies per person\
  \ | ✓ High confidence | Unit: USD/person/year | Click to view source\">$10</a>"
"sugar_subsidy_cost_per_person_annual_cite": "@sugar-subsidies-cost"
"switzerland_defense_spending_pct": "<a href=\"https://warondisease.org/knowledge/references.html#swiss-military-budget-0-7-pct-gdp\"\
  \ class=\"parameter-link\" data-source-ref=\"swiss-military-budget-0-7-pct-gdp\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Switzerland's defense\
  \ spending as percentage of GDP (0.7%) | ✓ High confidence | Unit: rate | Click\
  \ to view source\">0.7%</a>"
"switzerland_defense_spending_pct_cite": "@swiss-military-budget-0-7-pct-gdp"
"switzerland_gdp_per_capita_k": "<a href=\"https://warondisease.org/knowledge/references.html#swiss-vs-us-gdp-per-capita\"\
  \ class=\"parameter-link\" data-source-ref=\"swiss-vs-us-gdp-per-capita\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Switzerland GDP per capita | ✓ High\
  \ confidence | Unit: USD | Click to view source\">$93K</a>"
"switzerland_gdp_per_capita_k_cite": "@swiss-vs-us-gdp-per-capita"
"terrorism_deaths_911": "<a href=\"https://warondisease.org/knowledge/references.html#chance-of-dying-from-terrorism-1-in-30m\"\
  \ class=\"parameter-link\" data-source-ref=\"chance-of-dying-from-terrorism-1-in-30m\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Deaths from 9/11\
  \ terrorist attacks | ✓ High confidence | Unit: deaths | Click to view source\"\
  >2,996</a>"
"terrorism_deaths_911_cite": "@chance-of-dying-from-terrorism-1-in-30m"
"thalidomide_cases_worldwide": "<a href=\"https://warondisease.org/knowledge/references.html#thalidomide-scandal\"\
  \ class=\"parameter-link\" data-source-ref=\"thalidomide-scandal\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Total thalidomide birth defect cases\
  \ worldwide (1957-1962) | ~ Medium confidence | 95% CI: [10,000, 20,000] | Dist:\
  \ Lognormal | Unit: cases | Click to view source\">15,000</a>"
"thalidomide_cases_worldwide_cite": "@thalidomide-scandal"
"thalidomide_dalys_per_event": "<span class=\"parameter-link\" title=\"parameters.THALIDOMIDE_DALYS_PER_EVENT\"\
  >41,760</span>"
"thalidomide_dalys_per_event_latex": "$$\n28{,}800 + 12{,}960 = 41{,}760 \\text{ DALYs}\n\
  $$"
"thalidomide_deaths_per_event": "<span class=\"parameter-link\" title=\"parameters.THALIDOMIDE_DEATHS_PER_EVENT\"\
  >360</span>"
"thalidomide_deaths_per_event_latex": "$$\n900 \\text{ (cases)} \\times 40\\% \\text{\
  \ (mortality)} = 360 \\text{ deaths}\n$$"
"thalidomide_disability_weight": "<a href=\"https://warondisease.org/knowledge/references.html#thalidomide-survivors-health\"\
  \ class=\"parameter-link\" data-source-ref=\"thalidomide-survivors-health\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Disability weight for thalidomide\
  \ survivors (limb deformities, organ damage) | ~ Medium confidence | 95% CI: [0.32,\
  \ 0.48] | Dist: Lognormal | Unit: ratio | Click to view source\">0.4</a>"
"thalidomide_disability_weight_cite": "@thalidomide-survivors-health"
"thalidomide_mortality_rate": "<a href=\"https://warondisease.org/knowledge/references.html#thalidomide-scandal\"\
  \ class=\"parameter-link\" data-source-ref=\"thalidomide-scandal\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Mortality rate for thalidomide-affected\
  \ infants (died within first year) | ✓ High confidence | 95% CI: [35%, 45%] | Dist:\
  \ Lognormal | Unit: percentage | Click to view source\">40%</a>"
"thalidomide_mortality_rate_cite": "@thalidomide-scandal"
"thalidomide_survivors_per_event": "<span class=\"parameter-link\" title=\"parameters.THALIDOMIDE_SURVIVORS_PER_EVENT\"\
  >540</span>"
"thalidomide_survivors_per_event_latex": "$$\n900 \\text{ (cases)} \\times 60\\% \\\
  text{ (survival)} = 540 \\text{ survivors}\n$$"
"thalidomide_survivor_lifespan": "<a href=\"https://warondisease.org/knowledge/references.html#thalidomide-survivors-health\"\
  \ class=\"parameter-link\" data-source-ref=\"thalidomide-survivors-health\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Average lifespan for thalidomide survivors\
  \ | ~ Medium confidence | 95% CI: [50, 70] | Dist: Lognormal | Unit: years | Click\
  \ to view source\">60</a>"
"thalidomide_survivor_lifespan_cite": "@thalidomide-survivors-health"
"thalidomide_us_cases_prevented": "<span class=\"parameter-link\" title=\"parameters.THALIDOMIDE_US_CASES_PREVENTED\"\
  >900</span>"
"thalidomide_us_cases_prevented_latex": "$$\n15{,}000 \\times 6\\% = 900 \\text{ cases}\n\
  $$"
"thalidomide_us_population_share_1960": "<a href=\"https://warondisease.org/knowledge/references.html#us-census-world-population-1960\"\
  \ class=\"parameter-link\" data-source-ref=\"us-census-world-population-1960\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"US share of world population in 1960\
  \ | ✓ High confidence | 95% CI: [5.5%, 6.5%] | Dist: Lognormal | Unit: percentage\
  \ | Click to view source\">6%</a>"
"thalidomide_us_population_share_1960_cite": "@us-census-world-population-1960"
"thalidomide_yld_per_event": "<span class=\"parameter-link\" title=\"parameters.THALIDOMIDE_YLD_PER_EVENT\"\
  >12,960</span>"
"thalidomide_yld_per_event_latex": "$$\n540 \\text{ (surv)} \\times 60 \\text{ (yrs)}\
  \ \\times 0.4 \\text{ (weight)} = 12{,}960 \\text{ YLD}\n$$"
"thalidomide_yll_per_event": "<span class=\"parameter-link\" title=\"parameters.THALIDOMIDE_YLL_PER_EVENT\"\
  >28,800</span>"
"thalidomide_yll_per_event_latex": "$$\n360 \\text{ (deaths)} \\times 80 \\text{ (years)}\
  \ = 28{,}800 \\text{ YLL}\n$$"
"total_book_words": "<a href=\"/book-word-count\" class=\"parameter-link\" data-source-ref=\"\
  /book-word-count\" data-source-type=\"definition\" data-confidence=\"high\" title=\"\
  Total words in the book | ✓ High confidence | Unit: words | Click to view calculation\"\
  >171K</a>"
"total_research_funding_with_treaty": "<a href=\"/knowledge/economics/economics\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total global\
  \ research funding (baseline + 1% treaty funding) | ✓ High confidence | Formula:\
  \ GLOBAL_MED_RESEARCH_SPENDING + TREATY_ANNUAL_FUNDING | Unit: USD | Click to view\
  \ calculation\">$94.7B</a>"
"total_research_funding_with_treaty_latex": "$$\nTotalResearchFunding = \\$67.5B +\
  \ \\$27.18B = \\$94.68B\n$$"
"total_time_investment_hours": "<a href=\"/knowledge/solution/wishocracy#time-investment\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/wishocracy.qmd#time-investment\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Total time investment\
  \ (reading + actions) | ✓ High confidence | Formula: READING + ACTIONS | Unit: hours\
  \ | Click to view calculation\">14.7</a>"
"total_time_investment_hours_latex": "$$\nTotalInvestment = 14.3 + 0.45 = 14.75 \\\
  text{ hours}\n$$"
"traditional_phase3_cost_per_patient": "<a href=\"https://warondisease.org/knowledge/references.html#phase-3-cost-per-patient-113k\"\
  \ class=\"parameter-link\" data-source-ref=\"phase-3-cost-per-patient-113k\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Phase 3 cost per patient (median) |\
  \ ✓ High confidence | Unit: USD/patient | Click to view source\">$80K</a>"
"traditional_phase3_cost_per_patient_cite": "@phase-3-cost-per-patient-113k"
"traditional_phase3_cost_per_patient_example_48k": "<a href=\"https://warondisease.org/knowledge/references.html#clinical-trial-cost-per-patient\"\
  \ class=\"parameter-link\" data-source-ref=\"clinical-trial-cost-per-patient\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Example Phase 3 trial cost per patient\
  \ ($48K) | ✓ High confidence | Unit: USD/patient | Click to view source\">$48K</a>"
"traditional_phase3_cost_per_patient_example_48k_cite": "@clinical-trial-cost-per-patient"
"traditional_phase3_cost_per_patient_fda_example_41k": "<a href=\"https://warondisease.org/knowledge/references.html#trial-costs-fda-study\"\
  \ class=\"parameter-link\" data-source-ref=\"trial-costs-fda-study\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"FDA cited Phase 3 cost per patient ($41K)\
  \ | ✓ High confidence | Unit: USD/patient | Click to view source\">$41K</a>"
"traditional_phase3_cost_per_patient_fda_example_41k_cite": "@trial-costs-fda-study"
"treatment_acceleration_years_current": "<a href=\"https://warondisease.org/knowledge/references.html#fda-approval-timeline-10-years\"\
  \ class=\"parameter-link\" data-source-ref=\"fda-approval-timeline-10-years\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Traditional FDA drug development timeline\
  \ | ✓ High confidence | Unit: years | Click to view source\">17</a>"
"treatment_acceleration_years_current_cite": "@fda-approval-timeline-10-years"
"treaty_annual_funding": "<span class=\"parameter-definition\" title=\"Annual funding\
  \ from 1% of global military spending redirected to DIH | Unit: USD/year | Core\
  \ definition\">$27.2B</span>"
"treaty_annual_funding_latex": "$$\nFunding = \\$2,718B \\times 0.01 = \\$27.18B\n\
  $$"
"treaty_benefit_multiplier_vs_vaccines": "<a href=\"/knowledge/economics/economics#better-than-the-best-charities\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/economics.qmd#better-than-the-best-charities\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Treaty system\
  \ benefit multiplier vs childhood vaccination programs | ✓ High confidence | Formula:\
  \ TREATY_CONSERVATIVE_BENEFIT ÷ CHILDHOOD_VACCINATION_BENEFIT | Unit: ratio | Click\
  \ to view calculation\">10.3</a>"
"treaty_benefit_multiplier_vs_vaccines_latex": "$$\nMultiplier = \\frac{\\$155.1B}{\\\
  $15.0B} = 10.3\\times\n$$"
"treaty_campaign_annual_cost_amortized": "<a href=\"/knowledge/strategy/roadmap#campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/strategy/roadmap.qmd#campaign-budget\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Amortized annual\
  \ campaign cost (total cost ÷ campaign duration) | ✓ High confidence | Formula:\
  \ TOTAL_COST ÷ DURATION | Unit: USD/year | Click to view calculation\">$250M</a>"
"treaty_campaign_annual_cost_amortized_latex": "$$\nAnnualCost = \\$1B / 4 = \\$0.25B\n\
  $$"
"treaty_campaign_budget_lobbying": "<a href=\"/knowledge/appendix/fundraising-strategy#campaign-budget-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/fundraising-strategy.qmd#campaign-budget-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"low\" title=\"Political lobbying\
  \ campaign: direct lobbying (US/EU/G20), Super PACs, opposition research, staff,\
  \ legal/compliance (exceeds pharma $300M + MIC $150M) | ? Low confidence | 95% CI:\
  \ [$325M, $1.30B] | Dist: Lognormal | Unit: USD | Click to view calculation\">$650M</a>"
"treaty_campaign_budget_referendum": "<a href=\"/knowledge/appendix/fundraising-strategy#campaign-budget-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/fundraising-strategy.qmd#campaign-budget-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"medium\" title=\"Global referendum\
  \ campaign (get 208M votes): ads, media, partnerships, staff, legal/compliance |\
  \ ~ Medium confidence | 95% CI: [$180M, $500M] | Dist: Lognormal | Unit: USD | Click\
  \ to view calculation\">$300M</a>"
"treaty_campaign_budget_reserve": "<a href=\"/knowledge/appendix/fundraising-strategy#campaign-budget-breakdown\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/fundraising-strategy.qmd#campaign-budget-breakdown\"\
  \ data-source-type=\"definition\" data-confidence=\"medium\" title=\"Reserve fund\
  \ / contingency buffer | ~ Medium confidence | 95% CI: [$20M, $100M] | Dist: Lognormal\
  \ | Unit: USD | Click to view calculation\">$50M</a>"
"treaty_campaign_budget_super_pacs": "<a href=\"/knowledge/strategy/roadmap#campaign-budget\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/strategy/roadmap.qmd#campaign-budget\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Campaign budget\
  \ for Super PACs and political lobbying | ✓ High confidence | Unit: USD | Click\
  \ to view calculation\">$800M</a>"
"treaty_campaign_duration_years": "<a href=\"/knowledge/strategy/roadmap\" class=\"\
  parameter-link\" data-source-ref=\"/knowledge/strategy/roadmap.qmd\" data-source-type=\"\
  definition\" data-confidence=\"high\" title=\"Treaty campaign duration (3-5 year\
  \ range, using midpoint) | ✓ High confidence | Unit: years | Click to view calculation\"\
  >4</a>"
"treaty_campaign_total_cost": "<a href=\"/knowledge/appendix/fundraising-strategy#capital-structure-campaign-vs-implementation\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/fundraising-strategy.qmd#capital-structure-campaign-vs-implementation\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total treaty\
  \ campaign cost (100% VICTORY Social Impact Bonds) | ✓ High confidence | Formula:\
  \ REFERENDUM + LOBBYING + RESERVE | Unit: USD | Click to view calculation\">$1.00B</a>"
"treaty_campaign_total_cost_latex": "$$\nCampaignCost = \\$300M \\text{ (ref)} + \\\
  $650M \\text{ (lob)} + \\$50M \\text{ (res)} = \\$1.0B\n$$"
"treaty_campaign_viral_referendum_base_case": "<a href=\"/knowledge/economics/campaign-budget#base-case-scenario\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd#base-case-scenario\"\
  \ data-source-type=\"definition\" data-confidence=\"medium\" title=\"Base case viral\
  \ referendum budget (assumes flat $0.50/vote, optimistic) | ~ Medium confidence\
  \ | Formula: PLATFORM + VERIFICATION + PAYMENTS_FLAT_RATE | Unit: USD | Click to\
  \ view calculation\">$140M</a>"
"treaty_campaign_viral_referendum_realistic": "<a href=\"/knowledge/economics/campaign-budget#realistic-scenario\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd#realistic-scenario\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"Realistic viral\
  \ referendum budget (moderate tiered pricing) | ✓ High confidence | Formula: PLATFORM\
  \ + VERIFICATION + MODERATE_TIERED_PAYMENTS | Unit: USD | Click to view calculation\"\
  >$220M</a>"
"treaty_campaign_viral_referendum_realistic_latex": "$$\nBudget_{realistic} = \\$35M_{platform}\
  \ + \\$59M_{verification} + \\$126M_{tiered\\ payments} = \\$220M\n$$"
"treaty_campaign_viral_referendum_worst_case": "<a href=\"/knowledge/economics/campaign-budget#worst-case-scenario\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/economics/campaign-budget.qmd#worst-case-scenario\"\
  \ data-source-type=\"definition\" data-confidence=\"medium\" title=\"Worst-case\
  \ viral referendum budget (tiered pricing with increasing marginal costs) | ~ Medium\
  \ confidence | Formula: PLATFORM + VERIFICATION + TIERED_PAYMENTS | Unit: USD |\
  \ Click to view calculation\">$406M</a>"
"treaty_campaign_viral_referendum_worst_case_latex": "$$\nBudget_{worst} = \\$35M_{platform}\
  \ + \\$59M_{verification} + \\$312M_{tiered\\ payments} = \\$406M\n$$"
"treaty_campaign_voting_bloc_target": "<a href=\"/knowledge/strategy/roadmap#voting-bloc\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/strategy/roadmap.qmd#voting-bloc\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Target voting\
  \ bloc size for campaign (3.5% of global population - critical mass for social change)\
  \ | ✓ High confidence | Formula: GLOBAL_POPULATION × 3.5% | Unit: of people | Click\
  \ to view calculation\">280M</a>"
"treaty_campaign_voting_bloc_target_latex": "$$\nVotingBloc = 8.0B \\times 0.035 =\
  \ 280M\n$$"
"treaty_complete_roi_all_benefits": "<a href=\"/knowledge/figures/dfda-investment-returns-bar-chart\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/figures/dfda-investment-returns-bar-chart.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Treaty ROI\
  \ based on eliminating the 8.2-year post-safety efficacy lag (PRIMARY METHODOLOGY).\
  \ Total one-time benefit from disease eradication delay elimination divided by $1B\
  \ campaign cost. This is the primary ROI estimate for total health benefits. | ~\
  \ Medium confidence | Formula: DISEASE_ERADICATION_DELAY_TOTAL ÷ CAMPAIGN_COST |\
  \ Unit: ratio | Click to view calculation\">1.19M</a>"
"treaty_complete_roi_all_benefits_latex": "$$\nROI_{lag\\_elimination} = \\frac{\\\
  $1{,}286T}{\\$1.00B} = 1{,}286{,}242:1\n$$"
"treaty_dfda_cost_per_daly_timeline_shift": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Cost per DALY\
  \ averted from one-time timeline shift (8.2 years). This is a conservative estimate\
  \ that only counts campaign cost ($1B) and ignores all economic benefits ($27B/year\
  \ funding unlocked + $50B/year R&D savings). For comparison: bed nets cost $89.0/DALY,\
  \ deworming costs $4-10/DALY. This intervention is 700x more cost-effective than\
  \ bed nets while also being self-funding. | ✓ High confidence | Formula: CAMPAIGN_COST\
  \ ÷ DALYS_TIMELINE_SHIFT | Unit: USD/DALY | Click to view calculation\">$0.13</a>"
"treaty_dfda_cost_per_daly_timeline_shift_latex": "$$\n\\text{Cost/DALY} = \\frac{\\\
  $1.0B}{7.90B} = \\$0.127\n$$"
"treaty_expected_cost_per_daly_conservative": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Expected cost\
  \ per DALY accounting for 10% political success probability (conservative estimate).\
  \ Even at this pessimistic probability (1 in 10 chance of success), the intervention\
  \ is still 70x more cost-effective than bed nets ($89.0/DALY) and comparable to\
  \ deworming ($4-10/DALY). For reference: Ottawa Treaty (landmine ban) was called\
  \ a 'bold gamble' that succeeded with 164 countries signing. | ~ Medium confidence\
  \ | Formula: CONDITIONAL_COST_PER_DALY ÷ POLITICAL_SUCCESS_PROBABILITY_CONSERVATIVE\
  \ | Unit: USD/DALY | Click to view calculation\">$1.26</a>"
"treaty_expected_cost_per_daly_conservative_latex": "$$\nE[\\text{Cost/DALY}]_{10\\\
  %} = \\frac{\\$0.127}{0.10} = \\$1.27\n$$"
"treaty_expected_vs_bed_nets_multiplier": "<span class=\"parameter-link\" title=\"\
  parameters.TREATY_EXPECTED_VS_BED_NETS_MULTIPLIER\">70.7</span>"
"treaty_expected_vs_bed_nets_multiplier_latex": "$$\nE[\\text{Multiplier}] = \\frac{\\\
  $89}{\\$1.27} = 70\\times\n$$"
"treaty_lives_saved_annual_global": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness#lives-saved\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#lives-saved\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual lives\
  \ saved from 1% reduction in conflict deaths | ✓ High confidence | Formula: TOTAL_DEATHS\
  \ × REDUCTION_PCT | Unit: lives/year | Click to view calculation\">2,446</a>"
"treaty_lives_saved_annual_global_latex": "$$\nLivesSaved = 244,600 \\times 0.01 =\
  \ 2,446\n$$"
"treaty_peace_plus_rd_annual_benefits": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness#total-benefits\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#total-benefits\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Basic annual\
  \ benefits: peace dividend + dFDA R&D savings only (2 of 8 benefit categories, excludes\
  \ regulatory delay value) | ✓ High confidence | Formula: PEACE_DIVIDEND + DFDA_RD_SAVINGS\
  \ | Unit: USD/year | Click to view calculation\">$155B</a>"
"treaty_peace_plus_rd_annual_benefits_latex": "$$\nBenefits_{peace+RD} = \\$113.55B\
  \ + \\$41.5B = \\$155.05B\n$$"
"treaty_qalys_gained_annual_global": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness#peace-qalys\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#peace-qalys\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Annual QALYs\
  \ gained from peace dividend (lives saved × QALYs/life) | ✓ High confidence | Formula:\
  \ LIVES_SAVED × QALYS_PER_LIFE | Unit: QALYs/year | Click to view calculation\"\
  >85,610</a>"
"treaty_qalys_gained_annual_global_latex": "$$\nQALYs_{peace} = 2,446 \\times 35 =\
  \ 85,610\n$$"
"treaty_recurring_benefits_annual": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Truly recurring\
  \ annual benefits from 1% Treaty: peace dividend ($113.6B/year) + R&D savings ($41.5B/year).\
  \ Note: Health benefits are one-time timeline shifts, NOT included here. | ✓ High\
  \ confidence | Formula: PEACE_DIVIDEND + RD_SAVINGS | Unit: USD/year | Click to\
  \ view calculation\">$155B</a>"
"treaty_recurring_benefits_annual_latex": "$$\nRecurring_{annual} = \\$113.6B + \\\
  $41.5B = \\$155.1B\n$$"
"treaty_reduction_pct": "<span class=\"parameter-definition\" title=\"1% reduction\
  \ in military spending/war costs from treaty | Unit: rate | Core definition\">1%</span>"
"treaty_roi_historical_rate": "<a href=\"/knowledge/figures/dfda-investment-returns-bar-chart\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/figures/dfda-investment-returns-bar-chart.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Treaty ROI based\
  \ on historical rate of drug development (existing drugs only, conservative floor).\
  \ Total one-time benefit from avoiding regulatory delay for drugs already in development\
  \ divided by $1B campaign cost. | ✓ High confidence | Formula: HISTORICAL_PROGRESS_TOTAL\
  \ ÷ CAMPAIGN_COST | Unit: ratio | Click to view calculation\">251K</a>"
"treaty_roi_historical_rate_latex": "$$\nROI_{historical} = \\frac{\\$251T}{\\$1.00B}\
  \ = 250{,}920:1\n$$"
"treaty_roi_innovation_acceleration": "<a href=\"/knowledge/figures/dfda-investment-returns-bar-chart\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/figures/dfda-investment-returns-bar-chart.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"low\" title=\"Treaty ROI based\
  \ on lag elimination plus innovation acceleration effects (OPTIMISTIC UPPER BOUND).\
  \ Includes cascading innovation effects from eliminating Phase 2-4 cost barriers.\
  \ Research-backed 2× multiplier represents combined timeline and volume effects\
  \ (Nature 2023, Woods et al. 2024). | ? Low confidence | Formula: DISEASE_ERADICATION_PLUS_ACCELERATION_TOTAL\
  \ ÷ CAMPAIGN_COST | Unit: ratio | Click to view calculation\">2.38M</a>"
"treaty_roi_innovation_acceleration_latex": "$$\nROI_{acceleration} = \\frac{\\$2{,}572T}{\\\
  $1.00B} = 2{,}572{,}484:1\n$$"
"treaty_roi_lag_elimination": "<a href=\"/knowledge/figures/dfda-investment-returns-bar-chart\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/figures/dfda-investment-returns-bar-chart.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Treaty ROI\
  \ based on eliminating the 8.2-year post-safety efficacy lag (PRIMARY METHODOLOGY).\
  \ Total one-time benefit from disease eradication delay elimination divided by $1B\
  \ campaign cost. This is the primary ROI estimate for total health benefits. | ~\
  \ Medium confidence | Formula: DISEASE_ERADICATION_DELAY_TOTAL ÷ CAMPAIGN_COST |\
  \ Unit: ratio | Click to view calculation\">1.19M</a>"
"treaty_roi_lag_elimination_latex": "$$\nROI_{lag\\_elimination} = \\frac{\\$1{,}286T}{\\\
  $1.00B} = 1{,}286{,}242:1\n$$"
"treaty_total_annual_costs": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness#total-costs\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#total-costs\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ system costs (campaign + dFDA operations) | ✓ High confidence | Formula: CAMPAIGN_ANNUAL\
  \ + DFDA_OPEX | Unit: USD/year | Click to view calculation\">$290M</a>"
"treaty_total_annual_costs_latex": "$$\nTotalCosts = \\$0.25B + \\$0.04B = \\$0.29B\n\
  $$"
"treaty_total_complete_benefits_annual": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Truly recurring\
  \ annual benefits from 1% Treaty: peace dividend ($113.6B/year) + R&D savings ($41.5B/year).\
  \ Note: Health benefits are one-time timeline shifts, NOT included here. | ✓ High\
  \ confidence | Formula: PEACE_DIVIDEND + RD_SAVINGS | Unit: USD/year | Click to\
  \ view calculation\">$155B</a>"
"treaty_total_complete_benefits_annual_latex": "$$\nRecurring_{annual} = \\$113.6B\
  \ + \\$41.5B = \\$155.1B\n$$"
"treaty_vs_bed_nets_multiplier": "<span class=\"parameter-link\" title=\"parameters.TREATY_VS_BED_NETS_MULTIPLIER\"\
  >707</span>"
"treaty_vs_bed_nets_multiplier_latex": "$$\n\\text{Multiplier} = \\frac{\\$89}{\\\
  $0.127} = 701\\times\n$$"
"trial_capacity_cumulative_years_20yr": "<span class=\"parameter-link\" title=\"parameters.TRIAL_CAPACITY_CUMULATIVE_YEARS_20YR\"\
  >514</span>"
"trial_capacity_cumulative_years_20yr_latex": "$$\nCapacity_{20yr} = 25.7 \\times\
  \ 20 = 514 \\text{ years}\n$$"
"trial_capacity_multiplier": "<span class=\"parameter-link\" title=\"parameters.TRIAL_CAPACITY_MULTIPLIER\"\
  >25.7</span>"
"trial_capacity_multiplier_latex": "$$\nMultiplier = 48.8M \\div 1.9M = 25.7\n$$"
"trial_capacity_multiplier_10pct": "<span class=\"parameter-link\" title=\"parameters.TRIAL_CAPACITY_MULTIPLIER_10PCT\"\
  >257</span>"
"trial_capacity_multiplier_1pct": "<span class=\"parameter-link\" title=\"parameters.TRIAL_CAPACITY_MULTIPLIER_1PCT\"\
  >25.7</span>"
"trial_capacity_multiplier_2pct": "<span class=\"parameter-link\" title=\"parameters.TRIAL_CAPACITY_MULTIPLIER_2PCT\"\
  >51.4</span>"
"trial_capacity_multiplier_5pct": "<span class=\"parameter-link\" title=\"parameters.TRIAL_CAPACITY_MULTIPLIER_5PCT\"\
  >129</span>"
"trial_cost_reduction_factor": "<a href=\"https://warondisease.org/knowledge/references.html#recovery-trial-82x-cost-reduction\"\
  \ class=\"parameter-link\" data-source-ref=\"recovery-trial-82x-cost-reduction\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Cost reduction\
  \ factor demonstrated by RECOVERY trial | ✓ High confidence | 95% CI: [20, 150]\
  \ | Dist: Lognormal (SE: 20) | Unit: ratio | Click to view source\">82</a>"
"trial_cost_reduction_factor_cite": "@recovery-trial-82x-cost-reduction"
"trial_cost_reduction_pct": "<span class=\"parameter-definition\" title=\"Trial cost\
  \ reduction percentage (50% baseline, conservative) | Unit: rate | Core definition\"\
  >50%</span>"
"type_ii_error_cost_ratio": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#risk-analysis\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#risk-analysis\"\
  \ data-source-type=\"calculated\" data-confidence=\"medium\" title=\"Ratio of Type\
  \ II error cost to Type I error benefit (harm from delay vs. harm prevented) | ~\
  \ Medium confidence | Formula: TYPE_II_COST ÷ TYPE_I_BENEFIT | Unit: ratio | Click\
  \ to view calculation\">3,068</a>"
"type_ii_error_cost_ratio_latex": "$$\n\\frac{Cost_{delay}}{Benefit_{safety}} = \\\
  frac{7.90B}{0.00259B} = 3{,}050:1\n$$"
"type_i_error_benefit_dalys": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis#risk-analysis\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#risk-analysis\"\
  \ data-source-type=\"calculated\" data-confidence=\"low\" title=\"Maximum DALYs\
  \ saved by FDA preventing unsafe drugs over 62-year period 1962-2024 (extreme overestimate:\
  \ one Thalidomide-scale event per year) | ? Low confidence | Formula: THALIDOMIDE_DALYS_PER_EVENT\
  \ × 62 years | Unit: DALYs | Click to view calculation\">2.59M</a>"
"type_i_error_benefit_dalys_latex": "$$\n41{,}760 \\times 62 = 2.59M \\text{ DALYs}\n\
  $$"
"typical_ceo_hourly_rate": "<a href=\"https://warondisease.org/knowledge/references.html#ceo-compensation\"\
  \ class=\"parameter-link\" data-source-ref=\"ceo-compensation\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Typical CEO hourly rate | ✓ High confidence\
  \ | Unit: USD/hour | Click to view source\">$10K</a>"
"typical_ceo_hourly_rate_cite": "@ceo-compensation"
"us_alzheimers_annual_cost": "<a href=\"https://warondisease.org/knowledge/references.html#disease-cost-alzheimers-1300b\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-cost-alzheimers-1300b\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Annual US\
  \ cost of Alzheimer's disease (direct and indirect) | ✓ High confidence | \U0001F4CA\
  \ Peer-reviewed | 95% CI: [$302B, $408B] | Dist: Lognormal | Unit: USD | Click to\
  \ view source\">$355B</a>"
"us_alzheimers_annual_cost_cite": "@disease-cost-alzheimers-1300b"
"us_cancer_annual_cost": "<a href=\"https://warondisease.org/knowledge/references.html#disease-cost-cancer-1800b\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-cost-cancer-1800b\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Annual US\
  \ cost of cancer (direct and indirect) | ✓ High confidence | \U0001F4CA Peer-reviewed\
  \ | 95% CI: [$177B, $239B] | Dist: Lognormal | Unit: USD | Click to view source\"\
  >$208B</a>"
"us_cancer_annual_cost_cite": "@disease-cost-cancer-1800b"
"us_chronic_disease_spending_annual": "<a href=\"https://warondisease.org/knowledge/references.html#us-chronic-disease-spending\"\
  \ class=\"parameter-link\" data-source-ref=\"us-chronic-disease-spending\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"US annual chronic disease spending |\
  \ ✓ High confidence | 95% CI: [$3.30T, $5.00T] | Dist: Lognormal | Unit: USD/year\
  \ | Click to view source\">$4.10T</a>"
"us_chronic_disease_spending_annual_cite": "@us-chronic-disease-spending"
"us_diabetes_annual_cost": "<a href=\"https://warondisease.org/knowledge/references.html#disease-cost-diabetes-1500b\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-cost-diabetes-1500b\" data-source-type=\"\
  external\" data-peer-reviewed=\"true\" data-confidence=\"high\" title=\"Annual US\
  \ cost of diabetes (direct and indirect) | ✓ High confidence | \U0001F4CA Peer-reviewed\
  \ | 95% CI: [$278B, $376B] | Dist: Lognormal | Unit: USD | Click to view source\"\
  >$327B</a>"
"us_diabetes_annual_cost_cite": "@disease-cost-diabetes-1500b"
"us_heart_disease_annual_cost": "<a href=\"https://warondisease.org/knowledge/references.html#disease-cost-heart-disease-2100b\"\
  \ class=\"parameter-link\" data-source-ref=\"disease-cost-heart-disease-2100b\"\
  \ data-source-type=\"external\" data-peer-reviewed=\"true\" data-confidence=\"high\"\
  \ title=\"Annual US cost of heart disease and stroke (direct and indirect) | ✓ High\
  \ confidence | \U0001F4CA Peer-reviewed | 95% CI: [$309B, $417B] | Dist: Lognormal\
  \ | Unit: USD | Click to view source\">$363B</a>"
"us_heart_disease_annual_cost_cite": "@disease-cost-heart-disease-2100b"
"us_major_diseases_total_annual_cost": "<a href=\"/knowledge/solution/aligning-incentives#insurance-companies\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/solution/aligning-incentives.qmd#insurance-companies\"\
  \ data-source-type=\"calculated\" data-confidence=\"high\" title=\"Total annual\
  \ US cost of major diseases (diabetes, Alzheimer's, heart disease, cancer) | ✓ High\
  \ confidence | Formula: DIABETES + ALZHEIMERS + HEART + CANCER | Unit: USD | Click\
  \ to view calculation\">$1.25T</a>"
"us_major_diseases_total_annual_cost_latex": "$$\nTotal = \\$327B + \\$355B + \\$363B\
  \ + \\$208B = \\$1.253T\n$$"
"us_mental_health_cost_annual": "<a href=\"https://warondisease.org/knowledge/references.html#mental-health-burden\"\
  \ class=\"parameter-link\" data-source-ref=\"mental-health-burden\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"US mental health costs (treatment +\
  \ productivity loss) | ✓ High confidence | Unit: USD/year | Click to view source\"\
  >$350B</a>"
"us_mental_health_cost_annual_cite": "@mental-health-burden"
"us_military_spending_pct_gdp": "<a href=\"https://warondisease.org/knowledge/references.html#us-military-budget-3-5-pct-gdp\"\
  \ class=\"parameter-link\" data-source-ref=\"us-military-budget-3-5-pct-gdp\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"US military spending as percentage of\
  \ GDP (2024) | ✓ High confidence | Unit: rate | Click to view source\">3.5%</a>"
"us_military_spending_pct_gdp_cite": "@us-military-budget-3-5-pct-gdp"
"us_population_2024": "<a href=\"https://warondisease.org/knowledge/references.html#us-voter-population\"\
  \ class=\"parameter-link\" data-source-ref=\"us-voter-population\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"US population in 2024 | ✓ High confidence\
  \ | 95% CI: [330M, 340M] | Dist: Lognormal | Unit: people | Click to view source\"\
  >335M</a>"
"us_population_2024_cite": "@us-voter-population"
"value_of_statistical_life": "<a href=\"https://warondisease.org/knowledge/references.html#dot-vsl-13-6m\"\
  \ class=\"parameter-link\" data-source-ref=\"dot-vsl-13-6m\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Value of Statistical Life (conservative\
  \ estimate) | ✓ High confidence | 95% CI: [$5.00M, $15M] | Dist: Gamma (SE: $3.00M)\
  \ | Unit: USD | Click to view source\">$10M</a>"
"value_of_statistical_life_cite": "@dot-vsl-13-6m"
"victory_bond_annual_payout": "<span class=\"parameter-definition\" title=\"Annual\
  \ VICTORY bond payout (treaty funding × bond percentage) | Unit: USD/year | Core\
  \ definition\">$2.72B</span>"
"victory_bond_annual_payout_latex": "$$\nBondPayout = \\$27.18B \\times 0.10 = \\\
  $2.718B\n$$"
"victory_bond_annual_return_pct": "<span class=\"parameter-definition\" title=\"Annual\
  \ return percentage for VICTORY bondholders | Unit: rate | Core definition\">272%</span>"
"victory_bond_annual_return_pct_latex": "$$\nReturn = \\$2.718B / \\$1B = 2.718 =\
  \ 271.8\\%\n$$"
"victory_bond_funding_pct": "<span class=\"parameter-definition\" title=\"Percentage\
  \ of captured dividend funding VICTORY bonds (10%) | Unit: rate | Core definition\"\
  >10%</span>"
"victory_bond_investment_unit_usd": "<a href=\"/knowledge/strategy/roadmap#victory-bonds\"\
  \ class=\"parameter-link\" data-source-ref=\"/knowledge/strategy/roadmap.qmd#victory-bonds\"\
  \ data-source-type=\"definition\" data-confidence=\"high\" title=\"VICTORY bond\
  \ investment unit for retail investors | ✓ High confidence | Unit: USD | Click to\
  \ view calculation\">$1.00K</a>"
"vitamin_a_cost_per_daly": "<a href=\"https://warondisease.org/knowledge/references.html#vitamin-a-cost-per-daly\"\
  \ class=\"parameter-link\" data-source-ref=\"vitamin-a-cost-per-daly\" data-source-type=\"\
  external\" data-confidence=\"medium\" title=\"Cost per DALY for vitamin A supplementation\
  \ programs (India: $23-50; Africa: $40-255; wide variation by region and baseline\
  \ VAD prevalence). Using India midpoint as conservative estimate. | ~ Medium confidence\
  \ | Unit: USD/DALY | Click to view source\">$37</a>"
"vitamin_a_cost_per_daly_cite": "@vitamin-a-cost-per-daly"
"water_fluoridation_annual_benefit": "<a href=\"https://warondisease.org/knowledge/references.html#clean-water-sanitation-roi\"\
  \ class=\"parameter-link\" data-source-ref=\"clean-water-sanitation-roi\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Estimated annual global economic benefit\
  \ from water fluoridation programs | ✓ High confidence | Unit: USD/year | Click\
  \ to view source\">$800M</a>"
"water_fluoridation_annual_benefit_cite": "@clean-water-sanitation-roi"
"water_fluoridation_roi": "<a href=\"https://warondisease.org/knowledge/references.html#clean-water-sanitation-roi\"\
  \ class=\"parameter-link\" data-source-ref=\"clean-water-sanitation-roi\" data-source-type=\"\
  external\" data-confidence=\"high\" title=\"Return on investment from water fluoridation\
  \ programs | ✓ High confidence | Unit: ratio | Click to view source\">23</a>"
"water_fluoridation_roi_cite": "@clean-water-sanitation-roi"
"who_qaly_threshold_cost_effective": "<a href=\"https://warondisease.org/knowledge/references.html#who-cost-effectiveness-threshold\"\
  \ class=\"parameter-link\" data-source-ref=\"who-cost-effectiveness-threshold\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Cost-effectiveness\
  \ threshold widely used in US health economics ($50,000/QALY, from 1980s dialysis\
  \ costs) | ✓ High confidence | Unit: USD/QALY | Click to view source\">$50K</a>"
"who_qaly_threshold_cost_effective_cite": "@who-cost-effectiveness-threshold"
"workforce_with_productivity_loss": "<a href=\"https://warondisease.org/knowledge/references.html#chronic-illness-workforce-productivity-loss\"\
  \ class=\"parameter-link\" data-source-ref=\"chronic-illness-workforce-productivity-loss\"\
  \ data-source-type=\"external\" data-confidence=\"high\" title=\"Percentage of workforce\
  \ experiencing productivity loss from chronic illness (28%) | ✓ High confidence\
  \ | Unit: rate | Click to view source\">28%</a>"
"workforce_with_productivity_loss_cite": "@chronic-illness-workforce-productivity-loss"
"total_parameter_count": "346"
"total_latex_equation_count": "126"
"total_citation_count": "126"
